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ABSTRACT

Insulin receptor assays using canine liver membranes and
erythrocytes were validated for use In evaluating Insulin receptor
binding parameters within a healthy population of dogs.

Association,

dissociation, saturabllity and specificity were demonstrated for
Insulin receptors of canine liver membranes and erythrocytes.

Assay

precision was evaluated by measuring Interassay coefficient of
variation (liver membrane " 25.OX;

erythrocytes ” 9.3%).

Because the number of hlgh-affinity receptor sites and highaffinlty K^ were determined using physiological concentrations of
insulin,

they were considered to be more physiologically important

than the total number of receptor sites,

low-affinlty Kp and Ke, which

were derived using supra-physlologlcal concentrations of insulin.

X

The

maximum binding correlated with the number of high-affinity receptor

sites and Ke, but negatively correlated with high-affinity Kp.
In addition to correlating binding parameters within and between
tissues, the effects of sex, anesthesia and prednisone treatment were
evaluated.

Erthrocyte Insulin receptor binding did not correlate well

with liver insulin receptor binding (3 samples of 12 dogs;
correlation coefficient).

Pearson's

This lack of correlation was possibly due

to different mechanisms of receptor regulation or poor precision In
the liver membrane assays.
No significant differences were observed in mean values for
binding parameters observed when comparing male versus female dogs for
either

liver membranes

0.05).

However,

or erythrocytes using an unpaired t test (p >

there was a significantly greater variation in the %
XV

maximum binding and the number of high-affinity receptor binding sites
for erythrocytes among females (Prob (a greater F) - 0.0405

X

MB;

0.0035 Hi-Affinity Sites).
A significant decrease in the

X

maximum binding of erythrocyte

insulin receptors was observed as a result of anesthesia (paired t
test; p “ 0.028).
No significant changes in erythrocyte insulin binding were
observed in

6

male dogs given daily prednisone, when evaluated at 52

hours and 3 weeks after onset of treatment (paired t test;

p > 0.05).

Canine erythrocyte insulin receptors are a potentially valuable
tool In evaluating clinical syndromes where alterations in insulin
receptor binding may occur.

xv i

INTRODUCTION

Insulin Is a peptide hormone, having a molecular weight of 6000,
which is secreted by the beta cells of the pancreas.

It elicits a

number of biological responses and plays a central role in the
regulation of carbohydrate, fat and protein metabolism fFlier,

1983],

Although liver, muscle and fat tissues are the major physiological
targets of insulin, many other cell types are regulated by Insulin
rCzech,

1985].

Biological actions of insulin include the activation of transport
systems for hexoses, amino acids and certain ions.

Lipid and

carbohydrate metabolism are affected by insulin*s activation of
enzymes such as glycogen synthase and pyruvate dehydrogenase, as well
as inhibition of hormone sensitive lipase TCzech,

1985].

Insulin also

modulates DNA and mRNA synthesis, protein synthesis and cell growth
[Belcher & Bar, 1981].
Evidence suggests that the biological actions of insulin are
Initiated by the interaction of the hormone with specific cell-surface
receptors that mediate one or more cellular signaling mechanisms
TCzech.

1985].

These signaling mechanisms are Implemented by membrane

synthesis of one or more chemical mediators or second messengers which
have not been clearly identified [Belcher & Bar,

1981].

Insulin binding to its plasma membrane receptor Is altered in a
number of clinical disease states, resulting in insulin resistance
fBar, 1983],

Insulin resistance is defined as a condition where

greater than normal amounts of insulin are required to elicit a
quantitatively normal response.

Recognized clinical states of insulin

2

resistance Include diabetes mellltus (Type I & II ) , obesity. Cushings
syndrome (excess glucocorticoids!, acromegaly (excess growth hormone),
pregnancy, ketoacidosis,
sepsis, and burns.

Insulin antibodies, uremia, cirrhosis,

Mechanisms for this Insulin resistance Include

decreases In the number of receptor sites, decreases In receptor
affinity or both fBelcher & Bar, 1981’.

Insulin resistance may also

result from synthesis of defective Insulin molecules, abnormal Insulin
degradation,

insulin antibodies or post-receptor defects )Bar, 19831.

The term "physiological receptor" refers to the hormone-receptor
binding that occurs i^i vivo and is linked to a biological response in
vivo [Limbird, 1986).

The intent of radioreceptor assays is to

monitor the Interaction of this physiological receptor for a
particular hormone.

The basic methodology employed for direct studies

of insulin-receptor interactions Is the same as other competitive
protein binding assays.

A radiolabeled hormone or ligand is Incubated

with a suitable receptor preparation, then separated so that receptor
bound radioactivity is determined.

The specificity and saturabllity

of these binding interactions are determined by performing incubation
with various amounts of unlabeled hormone TKahn,

19761.

These

radioreceptor binding assays may be employed to evaluate physiological
and pathophysiological changes in receptor binding.
The use of radioreceptor assays involving erythrocytes or liver
membranes has not been thoroughly validated for use in the dog.

Since

there are recognized clinical syndromes of insulin resistance in dogs
TElgenmann & Peterson,

1984), it would be worthwhile to have a means

to evaluate the insulin receptor in these states of insulin
resistance.

Because of easy access to venous blood by venipuncture,

3

the erythrocytes have an obvious advantage over liver membranes,
obtained by liver biopsy, when evaluating insulin receptor status of
an animal.

If the erythrocyte insulin receptor represents the insulin

receptor status of insulin target organs (liver, muscle, adipose),
erythrocyte insulin receptor assays would be an ideal research tool
for studying clinical syndromes of insulin resistance.
The objectives of this study are:
i) to demonstrate that the radioligand binding to canine liver
membranes and erythrocytes, observed in the assays performed in this
study, actually represents the interaction of the physiological
receptor for insulin.

To confirm this hypothesis, the following

criteria will be demonstrated: a) association, b) dissociation, c>
saturability and d) specificity.

ii) To establish the range of variation and correlate the a) number of
receptor binding sites, b) receptor affinity and c) percentage of
maximum binding of insulin receptors of erythrocytes and liver
membranes from a sample population of healthy dogs.

iii) To determine the effects of administering glucocorticoids on the
a) number of receptor sites, b> receptor affinity and c) percentage of
maximum binding of insulin receptors of erythrocytes from male dogs.

LITERATURE REVIEW

I.

RECEPTOR STRUCTURE AND FUNCTION

In the early 1900*3, investigators theorized the presence of
"receptor substances" which reacted with given chemical agents to
evoke a biological response fBelcher & Bar, 19811.

In the 1920's,

A.J. Clarke proposed the simple hypothesis that the reaction between
an active substance and its specific receptor is a reversible process
governed by the law of mass action and that responses to the agent are
directly proportional to the fraction of specific receptor occupied by
the agent.
The roles of a ligand receptor are 1) to distinguish a particular
signal from a mixture of other hormones and molecules and

2)

to relay

this signal in such a manner that the appropriate cellular response
follows ^Baxter & Funder,

19791.

Demonstration of a hormone binding

site as a receptor requires it be purified and shown to elicit
appropriate physiologic action when it binds the hormone in a defined
system with proper controls.

Identification of hormone binding sites

as receptors has relied mainly on
binding and biological effects,

2)

11

correlation between hormone

genetic or other studies where

changes in receptors are associated with altered hormone
responsiveness, and 3) finding that receptor binding by anti-receptor
antibodies or antagonists attenuates or alters the hormone responses.
Understanding the recently elucidated insulin receptor structure
is important since receptor functions are determined by insulin
receptor structure rCzech.

1985].

Native cell surface insulin

5
receptors consist of

2

glycoprotein subunit types with apparent masses

of about 125,000-135,000 daltons (alpha subunits) and 90,000 daltons
(beta subunits).

The alpha and beta subunits are derived from a

single polypeptide precursor by one or more proteolytic cleavages.
The alpha subunit Is a glycoprotein containing an oligosaccharide and
sialic acid; the beta subunit Is also a glycoprotein containing
oligosaccharide.

The alpha and beta subunits seem to have distinct

functions in that the alpha subunit appears to bind the hormone
whereas the beta subunit appears to possess Intrinsic tyrosine kinase
activity.

The predominant subunit configuration in the native insulin

receptor is a disulfide-linked heterotetramerlc structure containing
alpha and

2

2

beta subunits.

The chemical mediator(s)
clearly defined.

for insulin response have not been

Other recognized second messengers such as cyclic

AMP, cyclic GMP, calcium, magnesium and H 2®2 were initially proposed
but not substantiated fLarner,

1983; Gammeltoft,

I9841.

The

observation that receptor-bound insulin was internalized suggested
that intracellular receptors,

insulin or proteolytic fragments may

elicit the biochemical actions.

This hypothesis has been dismissed

because blocking of internalization and cellular degradation did not
affect insulin activation of glucose transport and oxidation in fat
cells oramino acid transport in hepatocytes fGammeltoft,

19841.

Studies using antireceptor antibodies have shown that the
attachment of a monovalent Fab* fragment to an insulin receptor
inhibited insulin binding and bioactivity of the receptor.

If

multiple Fab* fragments were crosslinked on receptor complexes,
bioactivity of the receptor was restored.

the

This insulinomimetic effect

6

suggests that receptor crossllnklng or aggregation may be Important
for Insulin action [Cheng, 1985; Czech,

1985],

This evidence supports the theory that ligand binding by insulin
receptors results in

1

or more conformational changes in receptor

structure so that a variety of functions may proceed.

[Czech, 1985].

Some Investigators feel that a small peptide mediator or a family of
mediators are formed from cell membrane proteins or glycoproteins by a
process of limited proteolysis which is modulated by binding of
insulin to its receptor [Larner, 19851.
Proposed intracellular mechanisms for these mediators include 1)
control of phosphorylation,
calmodulin,

2)

control of affinity for calcium or

3) control of fluidity of membranes or 4) direct

allosteric effects [Jarett,

1983'.

Abnormal release or metabolism of

these mediators has been proposed as a mechanism for post-receptor
defects in insulin function resulting in insulin resistance [Jarett,
1983].
Other investigators support the theory that the insulin receptor
actually serves as an enzyme that catalyzes tyrosine
autophosphorylation of the beta subunit
(insulin receptor)

TCzech, 1985],

This enzyme

is activated by insulin hormone to activate

receptor tyrosine kinase activity.

An interrelationship has been

demonstrated between the proposed proteolytic formation of mediator(sl
and receptor phosphorylation fChang,

1985],

While insulin-receptor complex internalization probably does not
play an Important role in bioresponse as a second messenger,

it does

play a role in the cellular degradation of insulin as well as the
regulation of receptor concentration [Bergeron, £t^ al^. , 1985].

I_n

7

vivo studies In man suggest that Insulln-receptor complex
Internalization plays an Important role In the kinetic removal of
Insulin from the circulation.

Insulin removal by internalization Is a

major function in the liver* receiving portal blood high in Insulin
concentrations * but also occurs In extra-hepatic tissues fEaton *
1984].
The process whereby there is a decrease in response to hormone at
the cellular level has been called desensltlzation, tachyphylaxis or
down regulation [Belcher & Bar, 1981].
down regulation Include

1)

co-operative Interactions;

Proposed mechanisms for this

reduced receptor affinity due to
2)

reduced numbers of receptors due to a)

receptor release from membrane to the extracellular space, b)
receptors inactivated by conformational changes, cl membrane receptors
degraded at the cell surface, d) ligand binding to cell surface
receptors Inducing Internalization; 3) inhibition of de novo synthesis
of new receptors; 4) uncoupling of receptors from second
messengers/mediators and 5) blockage of the effector pathway distal to
the insulin-receptor interaction.
It is well recognized that insulin can inversely regulate the
number of cell— surface insulin receptors [Marshall & Olefsky,

1981].

The fact that the rate of receptor loss correlates with the
extent of insulin-receptor internalization, strongly suggests that
this is an important mechanism for down regulation of receptor.
[Marshall & Olefsky,

1981].

The insulin molecule is degraded while

the receptor is sequestered in Intracellular vesicles.
can be degraded or recycled to the cell membrane
Cuatrecagas,

1983],

These vesicles

Macobs &

8

Physiological modulators of Insulin receptors Include Insulin,
other hormones, exercise, meals, diet, age, c AMP, pH, ketones and
antireceptor antibodies [Bar, 19831.

Besides receptor

Internalization, there are other mechanisms for regulation of insulin
receptors.

As previously described, the microaggregation of receptors

resulting in conformational changes may be important for insulin or
antireceptor antibodies to attach to receptors for generating
intracellular signals.

Modification of the plasma membrane lipid

environment can also alter Insulin receptor function.

II.

ASSAY BINDING TECHNIQUES

A. THEORY

The direct study of insulin-receptor interactions utilizes
techniques similar to other competitive binding assays fFreychet,
1976].

Assays of insulin receptor binding have 3 fundamental

requirements:

M

a radioactively labeled hormone (radioligand),

2

) a

tissue receptor preparation and 3) a separation technique for
separating bound and free hormone fFreychet,
Limbird,

1976; Gammeltoft, 1984;

1986],

The reaction studied involves the binding of hormone,
receptor,

fR].

fH1, to its

This reaction behaves according to the law of mass

action i.e., the binding of a single ligand to a single population of
homogenous binding sites by a fully reversible reaction fLimbird,
1986],

This reaction is represented by the following equation:
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fH] + [R]

[HR]

where [H] * hormone (or *H - radiolabeled hormone)
[R] • receptor
THR] * hormone receptor complex
k^ - association rate constant
“ dissociation rate constant

An understanding of binding assay techniques requires an
knowledge of radiolabeling of hormones and the conditions of the
preparation of tissues containing receptors.

Variation in assay

conditions for incubation and separation can influence measured
binding as well.

There are specified criteria which must be met to

confidently establish that a radioligand binding assay really monitors
interaction at the physiological receptor for a particular hormone
[Limbird,

19861.

The term physiological receptor refers to that

hormone-receptor binding that occurs in vivo and is linked to a
biological response observed _in vivo.
Criteria to support the theory that binding sites identified
represent a genuine, "physiological receptor" include:

1)

Saturabllity - The binding should be saturable since a finite

number of receptors is expected in a biological preparation.
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2)

Specificity - The specificity of the hormone competing with the

radiolabeled hormone for binding to the receptor should parallel the
specificity of that hormone in eliciting its physiological effects.
3) Kinetics - The kinetics of binding should be consistent with the
time-course of the biological effect elicited by the hormone.
By definition, binding sites, which have been measured In binding
assays meeting the previous defined criteria, are considered to be
"physiological receptors"

B.

[Limbird, 1986].

RADIOLIGAND

A number of radioisotopes have been used in radloligand— receptor
I n c

binding techniques:

H,

I'll

I,

'I ^

I,

| i

P, and

C fLimbird,

19861.

Radiolabeled insulin used in binding studies must retain the
biological activity of the native unlabeled insulin and the specific
activity (amount of radioactivity per given mass) of the radiolabeled
insulin must be high enough to permit the use of low concentrations
(near the physiological values).

Because of these requirements,

is most often used to radiolabel insulin.

In addition,

obtained virtually carrier-free (i.e., close to
abundance),

100%

125

125

I

I can be

isotope

it is counted with high efficiency In most gamma counters

and it has a suitable half-life (60.2 days) for efficient use
rFreychet, 1976].
Xodlnatlon of insulin is commonly performed by one of two methods
[Freychet,

19761.

The chloramine-T method Involves the iodination of

microgram concentrations of insulin with Na
of the insulin being iodinated.

125

I with only about 10%

Chloramine-T is added stepwise until
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the desired degree of iodlnatlon Is achieved (usually 60-902 of the
Iodine is incorporated into insulin).

Iodlnatlon may also be

performed enzymatically with the use of lactoperoxldase to catalyze
the oxidation of iodine In the presence of
Frank, et a l . 1983].

fFreychet,

1976;

Iodlnatlon occurs on one or more of 4 tyrosine

residues in the insulin molecule (A14, A19, BI 6 , B26)

[Gammeltoft,

19841 .
Until recently, receptor— binding studies were performed with
heterogenous

125

I labeled insulin preparations fGammeltoft, 1984].

These lodlnated insulin preparations were composed of monoiodonated
and dllodinated isomers, aggregated insulin polymers and native
Insulin.

Some of these preparations showed decreased biological

activity due to oxidation damage and multiple iodine substitutions.
These preparations altered binding assay studies by increasing
non-specific binding and/or altering receptor concentrations or
affinity depending on the position of iodines.
Several laboratories have succeeded in purifying monolodolnsulln
by ion-exchange chromatography ^Gammeltoft, 19841 or high performance
liquid chromatography [Frank,

1983],

Homogenous preparations of

raonoiodoinsulln differ in bioactivity according to which tyrosine
residue on the insulin molecule is labeled.

Insulin iodinated at TYR

-A14 is fully active while insulin iodinated at TYR-A19 has attenuated
activity, suggesting that TYR-A19 is included in the receptor-binding
region of insulin.

Preparations of monoiodoinsulin labeled at TYR-B16

or TYR-B26 have Increased rates of association and the use of these
preparations tend to erroneously over-estimate receptor affinity.
relative binding affinities of the four homogenous monoiodoinsulin

The

12

preparations are as follows:
[Gammeltoft* 1984].

0 (A19), 1 (A14),

> 1 (B16 & B26)

In addition, the affinities of monoiodoinsulin

vary with the tissue and species being evaluated [Frank, e_t al^ 1983;
Podlecki, e ^ a l ,

1983].

Monoiodoinsulin labeled at TYR-A14 is felt by many investigators
to be an ideal radioligand to use in radioreceptor binding assays
because of its previously described bioactivity and binding affinity.
In addition, this preparation has shown bioactive and immunoreactive
stability for at least 6 months fLinde, et^
1984].

However,

1981; Gammeltoft,

in one report of binding studies, decreases in the

apparent number of binding sites occurred by approximately 0.13% per
day of aging.

The concentration of bioactive insulin in the

preparation decreases as a function of time because of the
disintegration of
molecule.

125

I causing an inactivation of the parent insulin

There was no significant effect on the affinity of insulin

to its receptor.

[Mattinen, et^ al, 1984],

C. RECEPTOR PREPARATIONS

Receptor preparations usually fal1 into one of 3 classes:
1> isolated intact cells, 2) particulate f ractions of cells and 3^
solubilized fractions of cells rFreychet,

1976; Kahn,

1976].

The study of isolated intact cells offers an advantage over
tissue fraction preparations.

The cells are metabolically active,

therefore both binding of insulin, as well as biological effects of
the hormone, can be measured.

Also, the measurement of binding can be

expressed per cell which is of interest when comparing binding
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capacities between various physiological and pathophysiological
states.

Use of intact cells circulating In the bloodstream

(monocytes, lymphocytes, and erythrocytes^ allows for easy
accessability [Freychet, 1976],
An advantage of particulate fractions of cells (cell membranes)
Is that they can be stored for several weeks or months and samples
from the same preparation can be repeatedly used.
membranes have been employed.

Two types of cell

One type consists of relatively crude

preparations which represent microsomal fractions.

These preparations

are prepared by differential centrifugation of the homogenate (usually
in 0.25 M sucrose).

The second type of cell membrane preparations,

which are highly purified membrane preparations, require more steps in
differential centrifugation.

Even the most highly purified

preparations are contaminated with 5-10% mitochondrial and microsomal
proteins while less purified membranes may contain up to 90% of these
contaminants [Freychet,

19761.

The advantage of the more purified

membranes include higher specific activity, lower non-specific binding
and minimal insulin degradation; whereas, less purified preparations
contain internal organelles which may possess specific or non-specific
hormone binding sites fKahn,

19761.

The purified membrane

preparations yield 10— 50% of the binding of less purified preparations
and may not reflect total cell binding.
Solubilized fractions of cells and cell membranes are
preparations where the receptor has been removed from its biological
membrane so that the receptor can be studied for its own
physlochemlcal properties rather than those of the membrane [Limbird,
19861.

There are obvious advantages to studying receptors in this

14

state.

Solubilization Is usually performed by biological detergents

(bile salts, physiological emulsions) and may Introduce alterations In
binding due to the effects of solubilization on membrane phospholipids
fKahn, 19761.

D. INCUBATION

The concentration of receptor-containing tissue and the duration
of incubation necessary to obtain detectable binding are influenced by
some of the consequences of the mass action law:

Association Rate ■ kj

THl rR]

Dissociation Rate - k ^ H R ]

At equilibrium

Association Rate

k L (H]

-

Dissociation Rate

[R] - k 2 rHR]

The ratio of bound H ( as ]HR] ) to the reactants is:

fHR]

-

kx

-------------[H1 fR]

where

K , molar ^
A
k2

- Equilibrium Association Constant
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and

f H ] fR ]

■

k2
“

Kp, m o l a r

fHR]

where

* Equilibrium Dissociation Constant

Kjj is most commonly used to represent the affinity of the
receptor because the units are molar rather than reciprocal molar.
represents the concentration of hormone that half-maximally occupies
the receptor at equilibrium.

An increase in

correlates with a

decrease in affinity.
Optimal incubation conditions are determined empirically for each
system and are chosen to optimize the formation of

*■

minimizing the degradation of f H] and fR]

&
\ HR]

while

[Limbird, 1986],

E. SEPARATION OF BOUND FROM FREE RADIOLIGANDS

To determine the quantity of bound radioligand one must have a

k

method of terminating the incubation which a1 lows separation of f H 1
(free radioligand)

from [ HR]

(bound radioligand).

Several methods

are available including equilibrium dialysis, centrifugation and
vacuum filtration.

Equilibrium dialysis Is theoretically the most
it

k

accurate way of determining f H] and

[

HR] because equilibrium is not

disrupted; however, there are some technical disadvantages.
Include cumbersome apparatus,

These

long incubation, nonspecific absorption

1 6'
*
of f Hi to chamber walls and low specific radioactivity above
background.
With centrifugation, the

*
HR] formed during Incubation Is

\

*

determined by pelleting the membranes leaving the f H] In the
supernatant.

Disposable mlcrofuge tubes are used so that

radioactivity within the pellet can be determined by cutting off the
tip of the mlcrofuge tube [Gambhlr,

1976; Limbird,

1986].

When utlllzing a single centrifugation of the incubation
suspension, trapping of free radioligand in the pellet can occur,
resulting in high background radioactivity.

Washing the pellet to
*
remove trapped free radioligand may effect f H R 1 because this complex
will have the opportunity to dissociate during washing.
alternative to washing,

An

to lower background radioactivity,

is to layer

the contents of the incubation above a solution of higher density
(sucrose, oil) in the centrifuge tube.

An important determinant as to

*

whether [ HRl dissociation will occur during the separation technique
Is the time required for the separation process.

Both lowering the

temperature to 4C to retard dissociation and centrifugation in
microfuges which can pellet particulate material within 5 seconds,
minimize r*HR] dissociation during separation.
In vacuum filtration, the bound radioligand is retained on a
filter while free radioligand passes through the filter.

Care must be

taken in filter selection and filter coating to minimize nonspecific
absorption of radioligand TLimbird,

19861.
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F. SATURABILITY

To determine whether the radioligand binding sites being examined
are Indeed the physiological

receptor* the sites should be

saturable, since a finite density of receptors Is predicted.

To

assess saturablllty, the characteristics of binding as a function of
Increasing concentrations of radioligand are determined.

When the

*
bound radioactivity [ HR] represents binding to a saturable receptor
A

(possessing a single affinity, K^, for the radioligand [ H]), the plot
*
*
of [ HR] versus [ H] yields a rectangular hyperbola:

[RJ total

[*HR]

Bound Radioligand

A

H

Free Radioligand

An Important consequence of the fact, a saturation isotherm
A

A

plotted as [ HR] versus [ H] Is a rectangular hyperbola. Is that the
horizontal asymptote is the total concentration of receptors (TR]
or B

max

1.

B

max

,
total

will only be attained at infinite concentration of
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*
[H] so ®max may be approached but never attained experimentally
[Belcher & Bar, 1981; Llmblrd,

1986],

G. SPECIFICITY

Another criteria for binding, which la expected for the
Interaction of the radioligand with the physiologically relevant
receptor,

Is that it should demonstrate specificity.

The specificity

with which the radioligand interacts with Its binding site Is
determined by competition binding studies, where the Incubation of
receptor-containing preparations with a constant concentration of
*

radioactivity [ H] is carried out in the presence of increasing
concentrations of unlabeled competitors such as insulin, prolnsulln,
desoctapeptlde Insulin and glucagon.

Data are plotted as X Specific

Binding versus L o g ^ Competitor Concentration [Gambhlr,
Freychet,

1976; Llmblrd,

1976;

1986].

100

X Specific
Binding

50

I n su l i n

Proinsulin

E C 50

E C 50

0

L o g ^ Competitor Cone.
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The relative potency of a hormone Is expressed as the
concentration of a competitor that reduces specific radioligand
binding detected in the absence of competitor by half ( E C ^ ) .

When

*
f H] Is Interacting with the physiologically relevant receptor, the
order of potency of unlabeled hormone competitors for binding to the
receptor should parallel the order of potency of these hormones in
promoting the physiological effect mediated via the receptor.

H. KINETICS

As previously stated, one of the expected criteria for the
binding of a radiolabeled hormone to the physiologically relevant
receptor is that the time course of binding should correspond to the
time-course characteristic of the physiological effect elicited by
[ H 1.

To quantitate the rate of binding of r Hi to its binding site,

the ratio of radioligand association to and dissociation from the
receptor is determined.
Specific binding is plotted against time to determine the

k
concentration of bound radioligand at equilibrium ([ H Ieq)*

This

information is then replotted to determine the association rate
constant

(k^).

To determine the dissociation rate constant (k^),

k

conditions are fixed so that association of f Hi and [R1 are
negligable and only dissociation can be measured.

Association is made

negligable by either "infinitely'' diluting the equilibrium solution or
by adding a large excess of unlabeled competing ligand so that
rebinding of the radioligand cannot occur.

*
The L o g ^ of the f HR] at

*
any time/ f HR] at the time dissociation was initiated is plotted
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against time.

The slope of this line is determined to be the

dissociation rate constant (k^).
Since Kp ” k^/k^,

the

is equivalent to the

can be calculated from kinetic data and

determined from saturablllty binding data if

*
binding of [ Hi to TRl represents binding to a single class of
receptor, which binds

[ H] in a reversible fashion with a fixed

affinity [Llmblrd, 19861.

I. NON-SPECIFIC BINDING

Specific binding is that binding resulting from the interaction
of the radioligand with the physiological

receptor.

However, some

of the radioactivity detected is actually due to radioligand binding
to other sites on the membranes, radioligand trapping in the pelleted
material or non-spec ifically absorbed on filters.
binding is referred to as "non-specific binding"

This low affinity
[Belcher & Bar,

1981;

Freychet, 1976].
Non-specific binding is often defined as that binding which
cannot be competed for by unlabeled ligand at a concentrat ion 100 X
of the unlabeled hormone.

Another definition of non-specific binding

is obtained mathematically using computer-assisted analysis.

This

model includes an algebraic description of the radioligand interacting
with saturable binding sites (specific binding) and a component of
binding that is non-saturable which increases binding with increasing
concentrations of radioligand (non-specific binding).

Specific

binding can be obtained by subtracting non-specific binding from total
binding.

fLImbird,

1986].
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SCATCHARD ANALYSIS

One of the most frequently used data transformations for
analyzing radioligand binding Is the so-called Scatchard plot [Weder,
e £ al^ 1974; Freychet, 1976; Belcher 4 Bar, 1981; Ganmeltoft,
Llmblrd,

1986],

1984;

The advantage of this analysis Is the potential

ability to estimate receptor density from the x-intercept and receptor
affinity from the slope of the plot.

In actuality, the Scatchard plot

utilized by most Investigators is actually the Rosenthal modification
of the original Scatchard analysis.
*
plots [ HR]

The Scatchard/Rosenthal method

*
f H] on the ordinate versus

[B]/[F] versus [B],

*
[ HR] on the abscissa or

This is true where B - the concentration of

radioligand bound in the radlollgand-receptor complex at equilibrium
and [F] “ the concentration of free radioligand present in the
Incubation at equilibrium.
From this plot, a linear expression of data can be obtained
according to the formula y - mx + b where m ” slope and b “
x-intercept:

X-intercept - B

tBj

Slope - - Ka - -1/Kp
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Since the negative reciprocal of the slope Is equal to
(Dissociation Rate Constant)

the receptor affinity (expressed as K^)

can be obtained.
The x-intercept is an estimate of the total receptor
concentration (B
or [R]
max
total

If n * number of binding sites /
°

receptor and you assume that there is 1 binding site per receptor,
therefore n * I, then n * [R1
, estimates
total
Rosenthal analysis,

fR1
,.
total

With the

the x - intercept is not an actual determination

of total receptor concentration ([RL „ ,) but a determination of the
total
total number of binding sites (n 0 fR] total)

K.

fLimbird,

19861.

INTERPRETATION OF THE CURVILINEAR NATURE OF THE
SCATCHARD/ROSENTHAL PLOT

Insulin receptor binding data transformations of fB)/TF“J versus TB1
are often observed to be curvilinear with an upward concavity.

The

biological interpretations of these findings include the possibilities
that 1) there are multiple orders of non-interacting binding sites
with unchanging and dissimilar affinities, 2) multiple affinity states
of the receptor exist as a consequence of receptor-hormone coupling
where a variable fraction of the total receptor population is coupled
to the hormone or 3) negative cooperativity exists where the affinity
of the overall receptor population decreases with increasing occupancy
of the receptors.

fLimbird,

1986; Gammeltoft, 1984]

Technical problems can also cause the artifactual appearance of
upward concave Scatchard plots.

Artifactual sources Include 11 an
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Inappropriate definition of non-specific binding, 2) the aggregation
of the ligand at higher concentrations to a dimer or multlmer that
possess a lower affinity for the receptor and 3) a difference in the
affinity of kinetic constants of [*H] and fH7 such that the receptor
possesses a greater affinity for f*Hl than rH],
Limbird,

[Pettersson, 1984;

1986]

Since steady state binding data cannot distinguish between
multiple,

independent populations of receptors possessing unchanging

affinities for ligands from populations where affinity decreases as
occupancy Increases, a kinetic approach was developed for an
Independent assessment of the possibility of negative cooperativity
among cell surface receptor binding sites fDeMeyts, et a_l, 1973;
DeMeyts, et al, 1976; Gammeltoft, 1984; Limbird,

1986].

Radioligand

is Incubated with target membranes unt11 binding reaches steady state.
This association phase is terminated by "infinite dilution" (usually
100-fold dilution of the incubation mixture is sufficient'*.

Infinite

dilution prevents further association of radioligand with the receptor
because the decreased concentration of [*H] and fR] decreases the
probability of radioligand-receptor interaction.
The rate of dissociation of the radioligand from the receptor is
monitored over time.

To determine whether negative cooperativity

exists, dissociation is monitored under 2 conditions:

infinite

dilution and infinite dilution in the presence of excess unlabeled
insulin.

If the receptor sites bind ligand independently, then the

filling of unoccuppled receptors with the excess unlabeled insulin
during the dissociation phase should not alter the rate of
dissociation of the radioligand.

If negative cooperativity among
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receptors exists, the filling of empty receptors with unlabled Insulin
will decrease the overall affinity of the receptor population and
accelerate the rate of radioligand dissociation rDeMeyts,
Llmblrd,

1986].

The kinetic analysis assumes that

of occupancy and suggest that

1973;

Is Independent

(which equals k£/k^) is Increased due

to an Increase In k^ fGammeltoft, 1984).
DeMeyts proposed a graphic analysis to describe the site-slte
Interactions occurring with negative cooperativity.

He developed a

new parameter, the average affinity of receptor sites, K, which is
calculated from (lBl/fF]/R ~[B] where R equals the x-intercept from
o
o
r
the Scatchard plot (B
or n
max

o fR] total.).

fractional occupancy (defined as rB] / .
made.

Plotting K as a function of
several observations can be

When binding sites are empty, a limiting high affinity, (K^),

can be obtained.

When 1 to 5% of the sites are occupied, K starts to

fall until a given level of occupancy (usually 25-50%) is reached
where a limiting low affinity (K^) is obtained.
termed the "average affinity profile" TDeMeyts,

The plot has been
1975].

The role of ligand-induced regulation of receptor binding
affinity in vivo is uncertain.

At low concentrations,

insulin could

bind to high affinity receptors, which then shift to the low affinity
state as insulin levels rise.

Negative cooperativity could maintain

insulin sensivitity at low concentrations but attenuate the cellular
response to higher concentrations and therefore buffer agalnst high
insulin secretions and reduce oscillations in insulin action.
rGammeltoft,

1984],

The interpretation of the kinetic phenomena in terms of negative
cooperativity has been challenged.

Evidence to support a 2-receptor
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model for Insulin binding was found In cultured embryonic heart cells
[Wheeler,

al^, 1980] .

Some researchers contend that the enhanced

radioligand dissociation at Increasing occupancy Is not definitive
proof for negative cooperativity [Levitzki, 1981; Gammeltoft,

1984].

Binding heterogeneity may be caused by insulin degradation rather than
negative cooperativity since correction for accumulated radiolabeled
insulin fragments in liver cells resulted in a linear Scatchard plot
[Donner, 1980].
Kinetic studies by one group of investigators suggest that there
are no cooperative interactions between binding sites and that the
hormone-receptor complex converts to a higher affinity state
subsequent to occupancy [Corin & Donner,

1982].

The proposed

mechanism for this 2-state model for the hepatic insulin receptor is a
conformational change in the receptor [Donner & Yonkers,

1983].

The 2 affinity state model has been revised and extended to
include 3 conformations of high (K ), intermediate (K 1 and low (K,)
s
e
E
affinltes.

The high affinity state (Kg) was found during the

association of insulin.

The altered affinity

may result from

removal of regulatory subunits of the receptor that modify binding
affinity by previously mentioned conformation changes or by positive
cooperative interactions rGammeltoft,

19841.

Pettersson, et al, found variability in the form of Scatchard
plots (linear to biphasic)
subjects.

in erythrocyte samples taken from the same

These findings support the proposal that an initially

homogenous class of insulin binding sites, upon exposure to insulin,
can appear in different forms with different binding affinities for
insulin.

These investigators propose that this could provide an ideal
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means to rapidly regulate erythrocyte response to Insulin [Pettersson,
e£ a l , 19841.

III.

TISSUE INSULIN RECEPTORS

Insulin receptor binding has been studied in a variety of tissues
[Gammeltoft, 1984].

Experimental evidence has accumulated to

demonstrate that receptors show tissue and species differences in
functional and structural characteristics.

One example of tissue

difference is the proposed exlstance of "spare receptors" in certain
tissues, such as fat but not in other tissues, such as liver.

The

spare receptor capacity provides a mechanism for obtaining a rapid
response at very low concentrations of hormone [Limbird,

1986].

These

differences may indicate the existence of receptor subtypes that are
linked to different physiologic actions of insulin [Gammeltoft, 1984],

A.

INSULIN RECEPTORS OF HEPATIC TISSUE

The liver's response to insulin stimulation is of major
importance due to the organ's vital role in glucose and fat
homeostasis.

A single class of receptors with a

of 7 X 10 ^

mol*

1 * was characterized In rat liver membranes fCuatrecasas, et a l .,
1971],

Other investigators observed 2 classes of receptors with

values of 5 X 10 ^

and 5 X 10 ^ mol*

[Kahn, e_t ail, 19741 .

1 * in rat liver membranes

Studies of isolated rat liver cells found no

evidence of heterogeneity in kinetic analysis of insulin receptors
[Gammeltoft,

19781.

Receptor mediated degradation of insulin in

2 7

hepatocytes was also demonstrated In this study.

Insulin receptors In

liver cells and membranes have been shown to display moderate negative
cooperative interactions fDeMeyts, 1976] and up-regulation has been
demonstrated In rat liver plasma membranes

B.

fCorln & Donner,

19811.

ERYTHROCYTE INSULIN RECEPTORS

Hepatocytes, adipocytes, monocytes and lymphocytes are the cell
types frequently used to reflect the Insulin receptor status of an
organism

TPettersson, et a l , 19841.

Monocytes and lymphocytes have

frequently been used to study insulin receptor binding in humans
because of their easy accessablllty fOgunwole, ^t^ al_, 1985] and have
been shown to reflect pathophysiologic states of insulin receptors in
target t issues TDons , et al_, 1981 ] .
Although the physiological significance of its role as an
insulin— sensitive cell is not fully established,

the erythrocyte has

been shown to possess specific insulin receptors

[Peterson,

19831 and

is therefore useful in the clinical evaluation of insulin receptor
status rGambhir, et a l , 1978; Ogunwole, et al, 1985; Dons, et a l ,
1981; Im, et^ al^, 1983],

Erythrocyte insulin receptors have been

evaluated in normal, obese, diabetic, ketoacidotic and hyperlipidemic
individuals as well as following fasting, feeding, exercise and
glucocorticoid treatment.

The obvious advantages of the erythrocyte

are the easy accessability and the small volume of blood (10 ml
compared to 60 ml for monocytes'* needed for assaying ^Pettersson, e^
a l , 1985].

Like other cells, specific membrane transport mechanisms

are present, membrane proteins are specifically organized and present,
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membrane proteins are specifically organized and calcium- dependent
ATPase activity Is evident TGambhlr, et a l , 1978].
Several studles have attempted to compare erythrocyte Insulin
binding results to those of target tissues obtained simultaneously.
One group of Investigators found a close correlation (r** 0.90) between
Insulin binding for mononuclear cells and erythrocytes In humans
TKobayashl, e_t al_t 1980] .

Another study correlated insulin receptor

binding on monocytes with that of erythrocytes (r* 0.62) in humans
[Ward, et^ al, 1981 ].
A third group of investigators found no significant change in
Insulin binding with either monocytes or erythrocytes in normal humans
given 40 mg of prednisone for 3 days rDons, at _al^ 1981].

However in

the same study, when poorly controlled Insulin-dependent diabetics
were evaluated after improved control,

there was a decrease in insulin

binding for monocytes but not erythrocytes.

They concluded that there

was a general relationship between monocyte and erythrocyte Insulin
binding but that important differences existed in the way the
receptors were regulated.
Researchers simultaneously evaluated insulin receptors of
erythrocytes and hepatocytes of rats with streptozotocin-induced
diabetes mellitus and found increases in binding for both erythrocytes
and hepatocytes fOkamato, et stl, 1982].

However,

the significant

Increase in binding of the hepatocytes was due to increases in both
receptor concentration and affinity, whereas, the increase in binding
of erythrocytes observed was not significant and due only to increases
in receptor concentration.

They concluded that insulin receptors of

rat erythrocytes were less sensitive to changes in plasma insulin
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concentrations and that erythrocytes do not always reflect accurately
the receptor status of hepatocytes.
Two points of controversy arise when deciding that erythrocyte
insulin binding Is or is not an Ideal model to reflect target tissue
Insulin receptor binding.

The first point of disaggreement concerns

the ability of the erythrocyte to up or down regulate insulin
receptors.

Because mature erythrocytes lack a nucleus and are not

capable of de novo protein synthesis, many researchers contend that
erythrocytes can not up or down regulate insulin receptors [Ginsberg &
Brown,

1982; Schulz, «jt^ al^, 1984; Gherzi, e^ a l , 19851.

a l , was unable to demonstrate,

Ginsberg,

in v itro, any significant changes in

receptor concentrations with mature erythrocytes incubated with
insulin in contrast to decreased receptor concentrations for
reticulocytes and primitive nucleated erythrocytes.

Gherzi, et a l ,

found that mature human erythrocytes were not able to change either
receptor numbers or affinity after tn vitro preincubation with high
concentrations of insulin.

Both Ginsberg, £t^ al_, and Gherzi,

al.

suggested that clinical studies utilizing erythrocytes be Interpreted
with caution because of this inability to down regulate Jja vitro and
that the erythrocyte may only be useful in reflecting chronic changes,
i.e., those that have occurred and been stable during the replacement
of the entire erythrocyte population.
Schulz found that in vitro studies using supraphyslologic
concentrations of insulin in the incubation medium showed no
significant alteration in insulin binding.

In contrast, the same

group of investigators found that in vivo studies involving a 5 hour
insulin clamp infusion, showed that specific insulin binding to
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erythrocytes decreased (due to affinity) in normal and diabetic
subjects [Schulz,

jrl, 1983].

They concluded that there were

factors, other than Insulin, which are Involved In the short-term
regulation of insulin receptor affinity of human erythrocytes and that
these factors are not effective under

vitro conditions.

Insel,

al [1960], also demonstrated down-regulation of Insulin binding to
monocytes and erythrocytes iji vivo in response to glucose/insulin
infusions.
Separate studies have suggested that down-regulatlon does occur
with erythrocyte insulin receptors and that this occurs due to
receptor Internalization rather than de novo protein synthesis
[Cambhir, et^ jil^ 1981; Peterson, et^ _al_, 1983].

Other researchers have

also documented acute changes in erythrocyte Insulin binding in vivo
[Bathena, ^t jQ,

1981; Okuno, et d ,

1983].

A second problem associated with the erythrocyte model is the
heterogeneity of insulin binding depending on the age of the
erythrocyte.

Tlvarsson & Thorell, 1985],

It has been shown that

insulin binding of erythrocytes is inversely and exponentially related
to cell age [Dons, et^ ^1L, 1981],
When erythrocytes were subjected to density fractionation to
separate erythrocyte populations according to age, insulin binding
correlated significantly with pyruvate kinase activity (a well known
marker for erythrocyte age) and reticulocyte counts [Ivarsson
Thorell,

1985; Camagna, et^ al_, 1983].

&

The correlation was greater for

pyruvate kinase activity than for reticulocyte counts.

However, these

researchers were unable to show a relationship between insulin binding
and age-related factors (pyruvate kinase activity and reticuloctye
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counts)

in unfractionated samples from individuals with normal

erythropolesls flnvarsson & Thorell,

19851.

Reticulocytes have been shown to have 10-20 times the insulin
binding capacity of mature erythrocytes [Peterson, et al^ 1983].
However, since reticulocytes compose less than 0.1Z of the total
erythrocytes population in normal individuals, the reticulocyte
population would only account for a maximum of

IX

of the total

specific insulin binding [Peterson, e^ al^, 1983],

IV.

THE EFFECTS OF GLUCOCORTICOIDS ON INSULIN RECEPTOR BINDING AND
GLUCOSE TOLERANCE

Insulin resistance was previously defined as a condition where a
greater than normal amount of insulin is required to achieve a normal
physiological response.

One of the major results of insulin

resistance is glucose intolerance with resulting hyperglycemia.
Proposed mechanisms for insulin resistance include insulin receptor
binding abnormalities, as well as, post-receptor defects lAmatruda,
1985].

A well recognized clinical cause of insulin resistance is

hypercortisolemia, either endogenously-induced or due to the
administration of glucocorticoids TElgenmann, 1984; Muggeo, 1983].
The hyperglycemia associated with glucocorticoids may be due to
increased hepatic gluconeogenesls (due to hepatic insulin resistance)
as well as decreased glucose utilization in peripheral tissues
(peripheral insulin resistance)
Pagano, e ^ ii^, 1984].

[Amatruda,

1985; Elgenmann,

1984;
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The effects of glucocorticoids on glucose tolerance have been
evaluated In dogs with various results depending on steroid
formulation, dose and duration of administration.

Glucocorticoid

administration In dogs increase hepatic gluconeogenesls [Ninomiya, et
a l . 1975; Tseekutz & Allen,
a l , 1986].

1972; Hetenyi, ejt **1^ 1980; Peterson, ^t^

Decreased peripheral glucose uptake due to

glucocortlcold-assoclated insulin resistance is not as well described
[Ninomiya, et a_l, 1975; Peterson, e_t trl, 1986].
Significant decreased Insulin sensitivity and glucose Intolerance
occurs in spontaneous canine hyperadrenocorticlsm fPeterson e£ a l ,
1981; Peterson, 1984; Elgenmann & Peterson, 1984], although 3 weeks of
1-2 mg/kg of prednisolone resulted in insignificant effects on insulin
secretion and glucose tolerance in healthy dogs.

In this study, the

only significant effect of glucocorticoid treatment was a mild
increase in fasting blood glucose concentrations

rWolfsheimer, et a l ,

1986].
An increase in insulin binding to erythrocyte insulin receptors
was shown In dogs treated with a single IV dose of 1 mg/kg of
dexamethasone [Dleberg, e£ al_, 1986] .
The effects of glucocorticoids on glucose tolerance, insulin
sensitivity and insulin receptors have been more extensively evaluated
in rats [Barton & Passingham,

1980; Olefsky, et a l , 1975; Olefsky,

1975; Kahn, e^ a^, 1978; Caro & Amatruda,
and humans fAmatruda, e^ j*l, 19851.

1982; Watanabe, £t al_, 1984]

Various glucocorticoids have been

evaluated in man, including hydrocortisone TDePirro, £t^ al^, 1980;
DePirro, ^t n l , 1981; Yasuda, e_t^ al_, 19821, prednisone rBeck-Nielson,
e t a l , 1980; Canivet, e t a1 , 1981; DePirro, et a l , 1980; Depirro, et
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al, 1981; Fantua, e_t al_, 1981; Muggeo, et a l , 1983; Yasuda & Kitabchi,
1980; Yasuda,

.®i* 1982], prednisolone TKan,

et a l , 1982] and dexamethasone fDePirro, e_t al,

el,

1985; Dvenger,

1980; DePirro e^t a l ,

1981; Yasuda & Kitabchi. 1980; Yasuda, et al 1982].
Increases [Fantus, et al,

1981; Kan, at al, 1985] and decreases

[DePirro, et al, 1980] in maximum binding of Insulin receptors have
been seen due to glucocorticoids.

Increases in the number of receptor

binding sites have been observed due to glucocorticoids TBeck-Nielsen,
_et_ a l , 1980; Canivet, et aJL, 1983].
and decreases fDePirro,

Increases fMuggeo, et a l , 1983]

a l , 1981; Yasuda & Kitabchi,

1980; Yasuda,

et a l , 1982] in receptor affinity have been observed due to
glucocorticoids.

Negligible changes in maximum binding, affinity

and/or the number of receptor binding sites, seen by some researchers,
suggest an important role for post-receptor defects In the insulin
resistance seen with glucocorticoids

fDvenger, e^ ^a^, 1982; Fantus, et

a l , 1981; Nosadinl, et^ al^, 1983; Rizza, £t^ jil_, 1982; Wajchenberg, et
a l , 1984; Watanabe, £t_ al_, 1984].
Individuals with spontaneous Cushing’s syndrome have shown either
no change in receptor binding or changes different (increased affinity
rather than decreased affinity)

than subjects administered exogenous

glucocorticoids rMuggeo, et a^,

1983; Nosadinl, e_t al,

Wajchenberg, et al,

1983;

1984],

One proposed explanation for the discrepencies seen in various
studies is that Increases in receptor number or affinity may be caused
by a direct effect of glucocorticoids, whereas the decreases in
receptor numbers or affinity may reflect a secondary response to
Increased circulating Insulin concentrations directly or indirectly
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produced by glucocorticoids (down-regulation)

rFantus, ejt trl,

Rlzza, et a l , 1982; Wajchenberg, et a l , 1984;

Borelli, et a l , 1982;

Barseghlan, ^t aQ,

1981;

1984],

Changes in insulin receptors observed in association with
glucocorticoids must be correlated with simultaneous in vivo tests to
evaluate glucose tolerance and insulin sensitivity in order to
interpret their physiological significance [Belcher & Bar, 1981;
Amatruda, et a l , 1985].

V.

EVALUATION OF INSULIN RECEPTORS IN DOCS

Insulin receptors have been evaluated to a 1imited extent In
dogs.

Insulin receptor binding on lymphocytes was measured in dogs

with experimentally Induced diabetes
1979].

mellltus fOrselli & Bouhaddicui,

Dogs made diabetic by surgical pancreatectomy had a decreased

number of binding sites on lymphocytes.
Insulin receptor binding was measured as a part of evaluation of
the glucose Intolerance associated with chronic renal failure In dogs
with surgically Induced renal failure [Akmal, et al^, 1985],
Investigators found no significant difference in binding capacity,
affinity or binding site concentrations of monocytes from normal dogs,
dogs with chronic renal failure with parathyroid glands and dogs with
chronic renal failure without parathyroid glands.
Monocyte Insulin receptor binding was measured in dogs with
streptozotocin-induced insulin deficient diabetes mellltus
fBevilacqua, et al,

1985].

There was no significant difference in
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affinity or the number of binding sites in control versus diabetic
dogs.
Hepatocyte and erythrocyte insulin binding was measured in
untreated spontaneously diabetic dogs and pancreatectomlzed dogs
[Church, 1984],

The pancreatectomized diabetic dogs showed increased

maximum specific binding for both hepatocytes and erythrocytes.

The

spontaneously diabetic dogs, which were all hypoinsulinemic, showed a
wide range of maximum specific binding compared to normal dogs.
Erythrocyte insulin receptors were measured in dogs before and
after fasting and treatment with dexamethasone TDieberg, et a_l, 1986],
There was no significant difference in maximum binding after a 72 hour
fast.

The single intravenous administration of dexamethasone (I

mg/kg) resulted in an increase in maximum binding of insulin which, at
Day 1 after treatment, was due to an increase in the number of binding
sites and, at Day 3 after treatment, was due to an Increase in
affinity.

METHODS

I. INSULIN BINDING ASSAY TECHNIQUES

A. HORMONES

1. RADIOLABELED HORMONE - The radioligand used In all binding studies
was a purified preparation of homogenous porcine
monolodo[TYR-A14]Insulin generously donated by Dr. Bruce Frank, Lilly
Research Laboratories Ta] [Frank, et al, 1983],

The radioligand used

was from one of 2 lots having a specific activity of either 308.88 or
365.00 mlcrocurles per microgram of insulin protein at a concentration
of 14 mlcrocurles/ ml of Insulin solution.

2. UNLABELED HORMONES - Glucagon was purchased from Sigma Chemical
Company [b].

Porcine insulin and proinsulin was a generous gift from

Dr. Bruce Frank, Lilly Research Laboratories

[a]Tc1.

DesoctapeptIde

porcine Insulin was a generous gift from Dr. Salvatore R a i d , National
Hormone and Pituitary Program fdl.

B. INSULIN RECEPTORS OF LIVER MEMBRANES

1. LIVER MEMBRANE COLLECTION & PREPARATION - Liver tissue was
surgically excised from anesthetized dogs.

Liver membrane homogenate

was prepared by a previously described method fBlrnbautner,

19781.

Liver tissue was immediately placed in cold (AC) 0.25 M sucrose 5mM
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tris buffer (pH 8) [Appendix 1A 7.

Approximately 1 gram of liver tissue

was homogenized with 20 ml of the sucrose buffer with a mechanical
homogenizer[e ] , maintaining the tissue in an ice bath (4C) at all
times.

Tissue homogenate was centrifuged

at 2500 RPM (500 G) for 15 minutes at 4 C .

[f] in polycarbonate bottles
The supernatant was

collected and centrifuged at 16,000 RPM (20,000 G) for 30 minutes.

The

supernatant was then aspirated and the remaining pellet was resuspended
In cold (4C) Krebs-Ringers-Phosphate buffer (pH 7.4) (BUFFER L)
fAppendix IB].

This suspension was centrifuged at 16,000 RPM (20,000

G) for 30 minutes at 4C.

The supernatant was aspirated and the pellet

was resuspended in 4 ml of Buffer L and frozen in 2 ml aliquots at -20C
unt11 assayed.

2. PROTEIN DETERMINATION - The protein concentration of the liver
membrane homogenate was determined by a modification of the Lowry
method [Lowry, et. jrl* 1951].

Liver membrane homogenate (100 ul) was

added to 400 ul of distilled water.
was added [Appendix 2],

To this, 3 ml of Lowry Solution

After 10 minutes of incubation at 24C, 0.3ml

of 1 N phenol reagent fb] was added, mixed and Incubated for 30 minutes
at 24C.

Absorbance was read at 750 nm on a spectrophotometer rg n and

protein concentration was determined from a standard curve using bovine
serum albumin (concentrations ranging from 50 to 1000 micrograms) as a
standard.

3. EFFECTS OF PH, TIME AND WASHING ON BINDING - Liver membrane
homogenate (2ml), prepared and stored according to the previously
described method, was thawed at 4C and combined with 100 ul of porcine
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monoiodo[TYR-A14]insulin and 6.9 ml of Buffer L.

Buffer L was adjusted

to a pH of 7.0, 7.4, 7.6 and 8.0 in four separate Incubation tubes
prior to the addition of liver membrane homogenate and radioligand.
The incubation and processing of the liver membrane homogenate and
radioligand was performed according to modifications of a previously
described method [Posner,

1974].

The mixture was Incubated in

triplicate at 24C and the reaction stopped at 0, 10, 20, 30, 60,

120,

180, and 240 minutes by the addition of 400 ul of the incubation
mixture to 1.5 microfuge tubes [h] containing 1 ml of cold (4C) Buffer
L at each pH.

Microfuge tubes were centrifuged for 3 minutes in a

microcentrifuge [i1 and the supernatant was aspirated.

Two of the

triplicate samples were washed a second time with 750 ul of cold Buffer
L, centrifuged for 2 minutes and the supernatant aspirated.

The

variation in processing of the triplicates of each sample was done to
evaluate the effects of single versus double washing [Llmbird,

19861.

All centrifugations

and washing procedures were performed in a 4C

refrigerated room.

The tips of the microfuge tubes containing the

membrane pellets were cut with a razor blade and placed in 12 X 75
glass tubes.

Each tube was counted for 2 minutes in a gamma counter

rJ ’.

4. EFFECTS OF TEMPERATURE ON BINDING - Liver membrane homogenate (2 ml)
prepared and stored as previously described, was thawed at 4C and
combined with 100 ul of porcine monoiodoTTYR-A141insulin and 6.9 ml of
Buffer L (pH 7.4).

Each incubation mixture (9 ml total volume for each

tube) was incubated

at 4C, 15C, 24C and 37C for 3 hours.

incubation reaction

was stopped at 0, 10, 20, 30, 60, 120,

The
180 and 240
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minutes by the addition of 400 ul of the Incubation mixture In
triplicate to 1.5 microfuge tubes containing 1 ml of cold (4C) Buffer
L.

Samples were centrifuged for 3 minutes In a microcentrifuge and the

supernatants were aspirated.

750 ul of Buffer L were added and samples

were centrifuged for 2 minutes.

The supernatants were aspirated and

the tips of the microfuge tubes containing the membrane pellets were
cut with a razor blade and placed In 12 X 75 mm glass tubes for
counting In a gamma counter.

All centrifugation and processing was

performed in a 4C refrigerated room.

5. SATURABILITY OF LIVER MEMBRANE INSULIN RECEPTORS - To assess
saturabillty, the characteristics of binding as a function of
increasing concentrations of radioligand were determined.
membrane homogenate in Buffer L (pH 7.4)

Liver

(300 ug protein/lOOul)

(200

ul) was incubated with 50 ul of unlabeled porcine insulin (non-specific
binding) or 50 ul of Buffer L (total binding) and 50 ul of radioligand
at various concentrations.
to 500 ng/ml.

Radioligand concentrations ranged from 0.5

The mixtures were incubated for 3 hours at 15C, then 100

ul aliquots were added

to 1000 ul of Buffer

Tubes were centrifuged

in a microcentrifuge for 3 minutes and the

supernatants were aspirated.

L in duplicate at 4 C .

Pellets were washed with 500 ul of Buffer

L, centrifuged for 2 minutes and the supernatants were again aspirated.
The tips of the microfuge cubes containing the membrane pellets were
cut with a razor blade

and placed in 12 X 75 glass tubes for counting

in a gamma counter for

5 minutes.
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6 . COMPETITIVE-INHIBITION BINDING WITH VARIOUS HORMONES - Specificity
of Insulin binding to liver membrane homogenate was demonstrated by
comparing the effects of various hormones on the binding of porcine
monolodo[TYR-A14]insulin with the membranes.

Radioligand 250 ul were

added to 5.3 ml of Buffer L (pH 7.4) to formulate the radioligand
solution.

Four ml of liver membrane homogenate were added to 4 ml of

Buffer L to formulate the membrane solution having a concentration of
86 ug of protein/lOOul.

Hormones for competitive binding included

porcine insulin, porcine prolnsulin, glucagon and porcine desoctapetlde
insulin.

Each hormone was serially diluted to obtain the following

concentrations:

10,000, 1,000, 500, 100, 50,

Liver homogenate solution (50 ul)

10, 5, 1 and 0 ng/ml.

6 unlabeled hormone solution,at each

concentrationjWere combined with the radioligand solution and incubated
at 15C.

The reaction was stopped after 3 hours by placing the

microfuge tubes containing the incubation mixtures in an ice bath (4C)
and adding 500 ul of cold (4C) Buffer L to each tube.
then centrifuged in a microcentrifuge for 3 minutes.

The mixture was
Supernatants were

aspirated, 500 ul of Buffer L were added and tubes were centrifuged
again for 2 minutes.

Supernatants were aspirated and the tips of the

microfuge tubes containing the membrane pellets were cut with a razor
blade and placed in 12 X 75 mm glass tubes for counting in a gamma
counter for 2 minutes.

7. DISSOCIATION OF BINDING - The rate of dissoclation of radioligand
from liver membrane homogenate was determined in the following manner
f5).

A 115 ul (4.92 ng) aliquot of radioligand was added to 7.385 ml

of Buffer L (pH 7.4) in tubes "1" and "2" and 7.185 ml of Buffer L and

200 ul (200 ug) of unlabeled Insulin were added to tube "3"
(non-apeclflc binding).

This radioligand solution was combined with

2.5 ml of liver membrane homogenate (86 ug protein/100 ul) giving a
total volume of 10 ml for each of tubes "1", "2” , "3".

The mixture was

Incubated for 3 hours at 24C and centrifuged for 10 minutes at 7,500
RPM at 4 C .

The supernatant was carefully aspirated.

The association

phase was terminated by diluting the Incubation mixture with a volume
(50 ml) of Buffer L sufficient to prevent rebinding of the radioligand
(so-called Infinite dilution).

The mixture was centrifuged for 10

minutes at 7,500 RPM (5,400 G1 at 4 C .

The supernatant was aspirated

and 10 ml of cold Buffer L (4C) was added to the pellet for
resuspension.

Triplicate samples (400 ul) were taken at 0 time and

added to microfuge tubes containing 750 ul of cold Buffer L in an ice
bath (4C) .

Next, all Incubation tubes were removed from the 4C ice

bath, kept at 24C while 200 ul of unlabeled porcine insulin was added
to tube *'2" (200 ul of Buffer L were added to tubes "1" and "3") and
timing was started.

Triplicate samples (400 ul) were taken from each

of tubes "I", "2" and "3" at the following times: 5, 10, 20, 30, 60,
120 and 180 minutes.

Each sample was added to 750 ul of cold Buffer L

in an ice bath (4C).

All microfuge tubes were centrifuged in a

microcentrifuge for 3 minutes.

Supernatants were aspirated and the

pellets were washed with 500 ul of cold Buffer L and re-centrifuged for
2 minutes.

Supernatants were aspirated;

the tips of the microfuge

tubes, containing the membrane pellets, were cut with a razor blade and
placed in 12 X 75 mm glass tubes for counting in a gamma counter for 2
minutes.
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. SCATCHARD ANALYSIS - Calculation of the total number of binding

sites by Scatchard analysis was determined by constructing complete
competitive-inhibition curves
following manner.
(pH 7.4)

[4].

The procedure was done in the

Fifty ul of liver membrane homogenate in Buffer L

(concentrations ranging from 395 to 458 ug of proteln/100 ul)

were incubated with 50 ul of radioligand (diluted in Buffer L to a
concentration of 1-3 ng/ml) and 50 ul of unlabeled porcine insulin
(diluted in Buffer L to gl ve concentrations of

0 ( 1, 5, 10,

75, 100, 150, 200, 300, 500, 750, 1000, 5000, 10,000 ng/ml)
triplicate in 1.5 ml microfuge Cubes.
3 hours at 15C.

15, 25,

50,

in

The mixtures were incubated for

At the end of 3 hours all samples were placed in a 4C

refrigerated room and 750 ul of cold Buffer L was added to all tubes.
Tubes were centrifuged in a microcentrifuge for 3 minutes and the
supernatants were aspirated.

The pellets were washed with 500 ul of

Buffer L, centrifuged for 2 minutes and the supernatants were again
aspirated.

The tips of the microfuge tubes containing the membrane

pellets were cut with a razor blade and placed
for counting in a gamma counter for

2

in

12 X 75 glass tubes

minutes.

a. INTERASSAY COEFFICIENT OF VARIATION - To evaluate the interassay
coefficient of variation of Scatchard analysis binding of insulin
receptors of canine liver membranes by the previously described method,
assays were performed on aliquots of the same liver membrane homogenate
on 5 consecutive days.
at both 15C and 24C.

The assays were incubated for 3 hours at pH 7.4

A3

9, DEGRADATION OF RADIOLIGAND - In each of the Scatchard analysis
performed, the percentage of degradation of the radioligand during the
experiment was determined by trichloroacetic acid (TCA)
precipitation [Gambhir, et al, 1978],

fl]

A SO ul aliquot of the

supernatant obtained after incubation and initial centrifugation, was
added to I ml of Buffer L and I ml of 10% TCA.
vortexed and centrifuged at 2000 RPM (850 G)

This mixture was

[k] for 10 minutes.

The

supernatant obtained was separated from the pellet and each portion was
counted in a gamma counter to obtain the percentage of radioactivity
remaining with the insulin protein and the percentage of radioactivity
separated from the insulin protein (% degradation).

C.INSULIN RECEPTORS OF ERYTHROCYTES

1.

ERYTHROCYTE COLLECTION AND PREPARATION - Whole blood was collected

from healthy dogs by jugular vein venipuncture with a syringe
containing CPD-AI

fm], an anticoagulant/preservative used to collect

and store canine blood for up to
transfusion fAppendix 3].
whole blood and mixed well.

6

weeks at AC for the purpose of

One ml of CPD-AI was added for every 7 ml of
The whole blood was refrigerated at AC

until the time of assay (less than or equal to 5 days),

then

centrifuged at AC for 10 minutes at 1500 RPM (500 G) fk1.

Erythrocytes

were processed by the technique described by Carabhir, et^ jrl, T1978],
Plasma was aspirated and erythrocytes were resuspended In an equal
volume of phosphate buffered saline (pH 7.A) (PBS)

[Appendix 1C],

This

suspension was then slowly layered over 3 ml of ficoll-hypaque media
[n] and centrifuged at 1800 RPM (700 G) for 20 minutes at AC.
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The supernatant containing P B S , monocytes, flcoll-hypaque, granulocytes
and the top portion of the erythrocyte layer were aspirated and the
remaining erythrocytes were resuspended in 2 parts of PBS.

The

flcoll-hypaque separation was repeated and the supernatant was again
aspirated.

The erythrocytes were resuspended In 10 ml of a Hepes

buffer (pH 7.6) (Buffer G)
at 1800 RPM (700 G) and 4C.

[Appendix 1D1 and centrifuged for 10 minutes
The supernatant was aspirated and Buffer G

was added to obtain a total volume of 5 ml.

The suspension was mixed

well and placed In an ice bath (4C) until assayed (within 30 minutes).
Erythrocyte concentration of the suspension was determined by
counting In a hemacytometer [ol.

A 25 ul aliquot of the suspension was

added to 3.8 ml of PBS and 200 ul of 0.4% trypan blue.

A 10 ul aliquot

of this mixture was added to a counting chamber of the hemocytometer,
The number of cells counted in 5 square mm boxes was multiplied by 10

9

to obtain the number of erythrocytes per ml.

2. EFFECTS OF PH, TIME AND TEMPERATURE ON BINDING - A series of
experiments varying pH, incubation time and temperature were performed
to determine the ideal binding conditions for canine erythrocytes.

a. VARIATION IN TEMPERATURE - Total binding tubes were prepared In the
following manner.

Eight ml of Buffer G (pH 8.0) and 200 ul of

radioligand were combined at 4C and then two ml of this mixture were
combined with

1

ml of erythrocyte suspension prepared by the previously

described method.

Non specific binding tubes were prepared by adding a

2 ml aliquot of a mixture of 7.6 ml of Buffer G (pH 8.0), 200 ul of
radioligand and 400 ul of unlabeled porcine insulin (400 ug)

to 1 ml of
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the erythrocyte suspension.

Duplicate 100 ul samples, taken from 4

Identical tubeB (both total and non-specific binding)

Intended for

Incubation at 4C, 15C, 24C, and 37C, were added to cold 400 ul
microfuge tubes To] containing
ul of Buffer G (pH 8.0)

100

ul of dibutyl phthalate [p] and 100

in an ice bath (4C^ .

The 4 temperature tubes

were then placed In water baths at the appropriate temperature and
timing started.

At 10, 20, 30, 45, 60,

minutes, duplicate

100

120, 180, 240, 300, 360

ul samples were taken from all temperature tubes

(both total and non-specific binding) and added to cold microfuge tubes
containing dibutyl phthalate and Buffer G as described above.
Microfuge tubes were centrifuged in a microcentrifuge for 2 minutes in
a refrigerated (4C) room.

The supernatants were aspirated and the tips

of the microfuge tubes containing the erythrocyte pellets were cut with
a razor blade and placed in 12 X 75 mm glass tubes for counting in a
gamma counter.

b. V A R I A T I O N IN PH A N D T E M P E R A T U R E 1.

EXPERIMENT 1 — Erythrocytes were collected and processed as

previously described.
containing

1

Eight separate assay systems were prepared each

ml of erythrocyte suspension combined with

radioligand suspension.

2

ml of

The erythrocyte suspension was prepared by

combining 200 ul of moniodo[TYRA14]insulin with 8.0 ml of Buffer G (pH
8.0) for total binding tubes and 200 ul of monlodoTTYR-A14]insulin with
7.6 ml of Buffer G (pH 8.0) and 400 ul of unlabeled porcine insulin
(400 ug) for non-specific binding.

Two assay tubes (one for total

binding and one for non-specific binding) were incubated at each of the
following temperatures: 4C, 15 C , 24C, and 37C.

Duplicate samples of
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100

ul were removed from each of the eight assay tubes at

0

,

10

,

20

,

30, 45, 60, 120, 180, 240, 300, and 360 minutes after combining the
Incubation mixture.

The samples were added to a cold 400 ul microfuge

tube containing 100 ul Buffer C and 100 ul of dlbutyl phthalate and
centrifuged for
(4C).

2

minutes in a microcentrifuge In a refrigerated room

The supernatant was aspirated and the tip of the microfuge tube

containing the pellet was

cut and placed In a 12 X 75 glass tube

for

counting for 5 minutes in a gamma counter.

2.

EXPERIMENT 2 - Erythrocytes were collected and processed as

previously described.

Five separate assay systems were prepared each

containing 1 ml of erythrocyte suspension combined with 10 ml of Buffer
G at 5 different pH*s (7.0, 7.4, 7.6, 8.0, 8.4).
was combined with 1 ml of

Buffer G for each pH.

Ten ul of radioligand
The radioligand

mixture (300 ul) was combined with 600 ul of the erythrocyte mixture
and Incubated for 4 hours at 4 C , 15C and 24C.
halted by adding

100

The incubation was

ul duplicated samples to cold microfuge tubes

containing 100 ul dibutyl phthalate and 100 ul Buffer G and centrifuged
for 2 minutes in a refrigerated room (4C).

The supernatants were

aspirated and the tips of the microfuge tubes containing the
erythrocyte pellets were cut and placed in 12 X 75 glass tubes for
counting in a gamma counter.

3. SATURABILITY OF ERYTHROCYTE INSULIN RECEPTORS

To assess saturability, the characteristics of binding as a
function of increasing concentrations of radioligand were determined.

200 ul of erythrocyte/Buffer G suspension (erythrocyte count " 4.5 X
109 cell/ml) was combined with 50 ul of unlabeled porcine Insulin
(non-specific binding) or 50 ul of Buffer G (total binding) and 50 ul
of radioligand at various concentrations.
ranged from 0.5 to 500 ng/ml.
for 4 hours;

then,

100

Radioligand concentrations

Tubes were incubated in an ice bath (4C)

ul of the samples,

in duplicate, were added to

cold microfuge tubes containing 100 ul of Buffer G and 100 ul of
dibutyl phthalate.

Tubes were centrifuged for 2 minutes in a

nilcrocentrifuge in a refrigerated room (4C).

The supernatant was

aspirated and the tip of the microfuge tubes containing the pellets
were cut and placed in 12 X 75 mm glass tubes for counting for 5
minutes in a gamma counter.

4. COMPETITIVE-INHIBITION BINDINC WITH VARIOUS HORMONES - Specificity
of insulin binding to canine erythrocytes was demonstrated by comparing
the effects of various hormones on the binding of porcine
monoiodoTTYRA-14] insulin to erythrocytes.
added to 1.6 ml of Buffer G (pH
solution.

8)

Radioligand (40 ul) was

to formulate the radioligand

Five ml of erythrocytes were combined with 1 ml of Buffer G

to formulate the erythrocyte suspension (erythrocyte count =* 8.97 X 10
9 cells/ml).

Hormones for competitive binding included porcine

insulin, porcine proinsulin, glucagon and porcine desoctapeptide
insulin.

Each hormone was serially diluted to obtain concentrations of

10,000, 5,000,

1.000, 750, 500, 300, 200,

5, 1, and 0 ng/ml.

150,

100, 75, 50, 25, 15, 10,

Radioligand (50 u l ) , unlabeled hormone (50 ul) at

each concentration and the erythrocyte suspension
Incubated for 4 hours at 4 C .

Duplicate

(200

ul) were

samples of 100 ul were added
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Co

cold 400 ul microfuge tubes containing 100 ul of Buffer C and 100

of

dlbutyl phthalate and centrifuged in a microcentrifuge in a

refrigerated room (4C) .
of

ul

The supernatants were aspirated and the tips

the microfuge tubes, containing the erythrocyte pellets, were cut

and placed In 12 X 75 glass tubes for counting for 5 minutes in a gamma
counter.

5.

DISSOCIATION OF BINDING - The rate of dissociation of radioligand

from erthrocytes was determined in the following manner.

Radioligand

(150 ul) was added to 2.1 ml of Buffer G (pH 7.6) in tubes "I" and "2".
Radioligand (150 u l ) , 2.0 ml of Buffer G and 100 ul of unlabeled
porcine insulin (100 ug) were added in tube ”3" (non-specific binding).
The radioligand solution (2.25 ml) was combined with 2.0 ml of
erythrocyte/Buffer G suspension to yield a total volume of 4.25 ml for
each of tubes "1", "2", "3".
at 4 C .

The mixtures were incubated for 4 hours

The association phase was terminated by diluting the incubation

mixture with a volume of Buffer G (50 ml) sufficient to prevent
rebinding of the radioligand.

The mixture was centrifuged for 10

minutes at 7,500 RPM (5,400 G) at 4 C , the supernatants were aspirated
and 50 ml of cold Buffer G were added to the erythrocyte pellets and
the centrifugation was repeated.

Supernatants were aspirated and the

erythrocyte pellets were resuspended with 3 ml of Buffer G.

The final

suspension of erythrocytes yielded an erythrocyte count approximately
9
equal to 3.5 X 10
were taken at

0

cells/ml for each tube.

Triplicate samples (100 ul'

time , added to cold microfuge tubes containing

100

ul

of Buffer G and 100 ul of dibutyl phthalate and centrifuged for 2
minutes in a refrigerated room (4C).

All incubation tubes were removed
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from the 4C ice bath, kept at 15C and 100 ul of porcine unlabeled
insulin (100 ug) was added to tube "2" (100 ul of Buffer G were added
to tubes "1" and "3").

Timing was started and at 10, 20, 30, 60,

180, and 240 minutes triplicate samples

(100

120,

ul) were taken from each

of tubes "1", "2" and ”3" and added to cold microfuge tubes containing
Buffer G and dibutyl phthalate.

The microfuge tubes were centrifuged

for 2 minutes in a refrigerated room (4C) , the supernatants aspirated
and the tips of the microfuge tubes, containing the pellets, were cut
and placed in 12 X 75 glass tubes for counting for 5 minutes in a gamma
counter.

6. S C A T C H A R D A N A L Y S I S

- C a l c u l a t i o n of

the

total n u m b e r of b i n d i n g

sites by Scatchard analysis was determined by constructing complete
competitive-inhibition curves.

An erythrocyte/Buffer G suspension (200
9

ul)

(erythrocyte count ■ 4.0 to 6.0 X 10

cells/ml) was combined with

50 ul of radioligand solution (diluted with Buffer G to a concentration
of 0.8 to

1.8

ng/ml) and 50 ul of unlabeled porcine insulin (diluted in

Buffer G to concentrations of 0, 1, 5, 10, 15, 25, 50, 75, 100, 150,
200, 300, 500, 750,
hours.

1000, 5000,

10,000 ng/ml)

At the end of the incubation period,

in an ice bath (4C) for 4
100 ul samples,

duplicate, were added to cold microfuge tubes containing

100

in
ul of

Buffer G and 100 ul of dibutyl phthalate and centrifuged for 2 minutes
in a microcentrifuge in a refrigerated room (4C).

The supernatant was

aspirated and the tip of the microfuge tube containing the pellet was
cut and placed in a 12 X 75 nun glass tube for counting for 5 minutes in
a gamma counter.
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a. INTERASSAY COEFFICIENT OF VARIATION FOR SCATCHARD ANALYSIS BINDING
ASSAYS - Based on the results of previously described experiments
designed to evaluate the effects of variation in pH, temperature and
incubation times on binding, parallel Scatchard analysis binding assays
were conducted at pH 7.6 and 8.0 at 4C for 4 hours on the same sample
of whole blood on 3 consecutive days and again on a second sample of
whole blood at pH 7.6 for 5 consecutive days.
determine:

This was done to

1) Optimum binding during Scatchard analysis assays and 2)

to determine the interassay coefficient of variation for the binding
assays.

7. RADIOLIGAND DEGRADATION - In each of the Scatchard analysis
performed, the percentage of degradation of radioligand during the
experiment was determined by TCA precipitation.

The supernatant

(100

ul aliquot) obtained after incubation and centrifugation was added to
ml of Buffer G and 1 ml of 10% TCA.
2000 RPM (850 G) for 10 minutes.

1

This mixture was centrifuged at

The supernatant was separated from

the pellet and each portion was counted in a gamma counter to obtain
the % radioactivity remaining with the insulin protein (pellet) and the

X

of radioactivity separated from the insulin protein (supernatant)

degradation).

(X
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II. DETERMINATION OF INSULIN RECEPTOR BINDING PARAMETERS FOR A CANINE
SAMPLE POPULATION

A.

ANIMALS

1. HOUSING AND ENVIRONMENT - Twelve healthy mature Beagle dogs frl
males,

6

(6

intact females), ranging In age from 1 to 4 years were used to

determine the range of values obtained for receptor binding parameters
In healthy dogs.

These dogs were housed outdoors with 2 dogs of the

same sex placed in each run.
for at least

6

The dogs had been housed in the same runs

months prior to onset of the study.

conducted from March through May for a period of

6

The study was
weeks so that there

was a change of photoperiod exposure for the dogs during the study.

2. DIET AND WEIGHT - Dogs were fed a constant commercial dry dog food
fs] [Appendix 4] once daily in the early afternoon.
consumed by the dogs varied from
maintain a constant body weight.
kg.

11-21

The amount of food

grams/kg of body weight to

The dogs weighed from 10.5 to 14.5

The average weight change for all dogs during the study was +0.7

kg with a range of -0.9 to +1.4 kg.

Weight changes were less than 5%

of total body weight in all but 2 dogs which had weight changes of 7.8
and 9.4% during the study.

All dogs were maintained within 10% of

ideal body weight during the study.

3. MINIMUM DATA BASE - A laboratory minimum data base was performed in
all dogs to evaluate health.

Laboratory evaluation included heartworm
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microfilaria test, complete blood count, urinalysis and biochemical
profile for serum blood urea nitrogen, creatinine, sodium, potassium,
chloride, total protein, albumin, alkaline phosphatase, alanine
transaminase, and aspartate transaminase activity.

a.

GLUCOSE TOLERANCE - Glucose tolerance was evaluated by measuring

serum glucose and insulin concentrations in response to an intravenous
dose of glucose (500 mg/kg)

fFigure P

(Wolfsheimer, et^ al,

1986],

All

blood samples were collected through an indwelling Jugular catheter.
Samples were taken at 0, 5, 10, 15, 25, 35, 45, 60 minutes to determine
1)

serum glucose concentration in fasting dogB, ill serum insulin

concentration in fasting dogs, iii) fractional clearance rate of
glucose, iv) insulin peak response, v) total insulin secreted and vi)
insulinogenic index.

The fractional clearance rate was calculated as

the slope of the line (0.693/ t 1/2 X 100, as percentage per minute)
for plasma glucose values taken between 15 and 45 minutes.

The insulin

peak response was considered to be the highest increment of serum
insulin above the base-line (sample taken before IV glucose) serum
insulin concentration.

Total insulin secretion was estimated as the

total incremental insulin area above the baseline during the 60 minutes
of the test.

The insulinogenic index was defined as the ratio of

insulin peak response to the greatest glucose increment above the
concentration in fasting dogs.

1.

SERUM GLUCOSE DETERMINATIONS - Serum samples for glucose

determination were collected in a clot tube, allowed to clot and
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A s s e s s m e n t of g l u c o s e t o l e r a n c e and i n su l i n s e c r e t i o n
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insu lin, u l U / m l ).
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centrifuged.

The serum was removed within 30 minutes.

Samples were

frozen at — 20C until glucose determination was performed by a
spectrophotometrie method rg] using the glucose oxidase method [t].

A

reference range of canine plasma glucose concentration was determined
from 26 healthy dogs
(■ 1 SD ■

2.

8

to be between 80 and 108 mg/dl with a mean of 93.6

.6 ) using the same method.

SERUM INSULIN DETERMINATION - Serum samples for insulin

determination were collected in a clot tube, allowed to clot and
centrifuged.

The serum was removed within 30

-20C until assayed.

minutes and frozen at

Insulin values for serum samples were determined

by radioimmunoassay, using a commercially available kit for use in
humans Tu] [Wolfsheimer, e£ al^, 19861 .

Specificity for canine insulin

was evaluated by demonstrating dilutional parallelism between standard
solutions commercially provided and serial dilutions of endogenous
insulin in canine serum.

Biological specificity was demonstrated by

revealing that injected glucose stimulated an Increase in serum insulin
concentrations in healthy dogs, as well as, by measurement of increased
insulin concentrations (84 ull'/ml) in a fasted dog with histologically
confirmed pancreatic B-cell adenocarcinoma.

Accuracy was demonstrated

by the addition of porcine insulin (because the amino acid sequence was
identical for pore ine and canine insulin and purif led canine insulin
was unavailable) to canine serum in concentrations from 4 to 200
ulU/ml.

Linear regression analysis of the recovery curve demonstrated

a correlation coefficient (r) of 0.998.

Low-end sensitivity for the

assay, defined as the apparent concentration 2 SD below the counts at
maximum binding, was I ulU/ml.
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The lntra-assay precision for 18 replicates of canine serum, with
a mean concentration of 38.3 ulU/ml, revealed a coefficient of
variation of 3.7%.

The Interassay coefficient of variation for 9

assays on the same canine serum sample was 13%.

The reference range of

insulin concentrations in canine serum determined from 61 healthy dogs
of various breeds (31 males and 30 anestral females), was 2.6 to 20.0
ulU/ml.

4.

The means was 7.8 (i 1 SD ■ 3.9).

ESTROUS CYCLE EVALUATION IN BITCHES- Cytologic evaluation of

vaginal epithelium was performed to estimate the stages of the estrous
cycle for each bitch [Appendix 51.

Cotton swabs dampened with sterile

0.9% saline were rotated within the vaginal vault to obtain epithelial
cells and then the swabs were rolled on a glass slide.

Slides were

stained with a Wright's stain and examined microscopically [91.
Vaginal cytology was examined every 2 weeks for 2 months prior to and
during the

6

week study.

Results of these smears along with physical

examination of the external genitalia were used to determine stages of
the estrous cycle for each bitch.

5.

HEALTH MAINTAINANCE- All dogs were vaccinated for distemper,

rabies, leptospirosis, CAV hepatitis, parainfluenza and parvo virus 3
months prior to onset of the study.

Ivermectin [v] was administered

orally once each month at a dose of 0.05 mg/kg as a heartworm
preventative and to aid in the control of intestinal parasites.

The

Ivermectin was not administered within 72 hours of any tissue or blood
sampling.

No other medications other than anesthesia were administered

during the study.
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B.

EXPERIMENTAL DESIGN- The 12 dogs were assigned Co 4 groups of 3

dogs so thac a group of 3 dogs was sampled each week for
3 dog group contained either 2 males and 1 female or
male.

C.

2

weeks.

6

Each

females and 1

Each dog was sampled 3 times at 2 week Intervals.

fFigure 21

SAMPLE COLLECTION - Dogs were fasted 24 hours prior to sampling.

Indwelling cephalic catheters were placed and general anesthesia was
induced by the administration of pentathal sodium [w] at a dose of
mg/kg Intravenously.

11

Dogs were Intubated and anesthesia was maintained

by inhalation of methophane fx]/02.

All dogs were maintained on

intravenous 0.91 saline at a rate of 2 ml/mlnute for the duration of
anesthesia which ranged from 45 minutes to 1.5 hours.

Whole blood (15

ml drawn from the Jugular vein into a syringe containing 2 ml of
CPD-AI) was obtained approximately 10 minutes after the induction of
anesthesia.

This sample was well mixed and stored at 4C until assayed.

Each blood sample was assayed twice (16 hours later and 64 hours
later).

In 9 of the 12 dogs, on one occasion 7 ml of whole blood was

drawn from the jugular vein and mixed with 1 ml of CPD-AI prior to the
Induction of anesthesia.

This was done to assess the effects of

anesthesia on erythrocyte insulin receptor binding.
Liver membranes were obtained by surgical laparoscopy.

The

abdomen was surgically prepped and inflated with either room air,
nitrous oxide or carbon dioxide with an insuflator placed through a
cm incision off the ventral abdominal midline.
performed by positioning the laparoscope
through a

2

[z]

Laparoscopy was

into the abdominal cavity

cm incision, just off the ventral midline approximately

cm cranial to the umbilicus TFigure 3 1.

1

Visualized biopsy was

2
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Figure 2.

Experimental design for liver tissue and erythrocyte sampling
of

12

beagle dogs.

Dog

Week
3/10/86
1
2

3

4

5

1

A

B

C

2

A

B

C

3

A

B

C

6

4

A

B

C

5

A

B

C

6

A

B

C

4/12/86
7

9

8

10

7

A

B

C

8

A

B

C

9

A

B

C

11

10

A

B

C

11

A

B

C

12

A

B

C

12
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Figure 3a-

Surgical laparoscopy for collection of liver tissue from
a beagle dog.

Figure 3b.

Surgical laparoscopy for collection of liver tissue from
a beagle dog.
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performed with a Storz biopsy forcep [aa] through another 1 cm incision
off the midline.

Eight to 14 pieces of tissue (each weighing 0.1 to

0.2 grams per piece) were harvested per liver biopsy procedure.

Tissue

was placed In cold 0.25 M sucrose, 5mM tris buffer (pH 8.0) In an ice
bath (4C) and later processed as described in the previous section.
Two aliquots containing 2 ml of liver membrane homogenate were frozen
at -20C for each sampling.

D.

DATA OBTAINED - The following parameters were measured from the

following samples:
1.

SAMPLES: a) 3 samples of erythrocytes taken from each of 12
dogs under anesthesia at
b)

2

week intervals.

1 sample of erythrocytes taken from 9 dogs 30
minutes

prior to anesthesia and collection of

anesthesized samples.
c) 3 samples of liver membranes taken from

12

dogs

under anesthesia at the same time of erythrocyte
collection at
2.

2

week intervals.

PARAMETERS MEASURED FROM SCATCHARD ANALYSIS OF EACH SAMPLE:
s') Percentage of maximum binding.

This value was

calculated from the sample containing radioligand
and the receptor suspension with no unlabeled
insulin.
Total number of receptor sites (per erythrocyte or
pg of liver protein).

This value was calculated
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from the x-intercept

(Binax or Ro) of the

lov-affinity portion (horizontal) of the curve.
c) Number of high-affinity receptor sites.

This

value was taken from the x-intercept (Bmax or Ro)
of the high-affinity portion (vertical) of the
curve.
d) High affinity constant (High K ^ ) .
equal to -

1 /slope

This value was

for the vertical portion of the

curve.
e) Low affinity constant (Low K ^ ) .

This value was

equal to - 1 /slope for the horizontal portion of
the curve.
f) Empty- site affinity constant (Ke).

This value

was taken frora the average affinity profile.

E.

STATISTICAL ANALYSES- Comparisons of binding data between and

within liver membranes and erythrocytes were made by Pearson's
correlation coefficient.

The effects of anesthesia on erythrocyte

insulin receptor binding were evaluated by a Student's paired t test.
For an estimate of variation of binding parameters for liver membranes
and erythrocytes within and among
performed.

dogs, an analysis of variance was

The effect of sex on binding parameters was evaluated by an

unpaired t test.
significant when

Correlations and differences were considered
p < 0.05.
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III.

THE EFFECTS OF GLUCOCORTICOID ADMINISTRATION ON GLUCOSE

TOLERANCE, INSULIN SECRETION AND ERYTHROCYTE RECEPTOR BINDING IN

6

MALE

BEAGLE DOGS.

The

6

male dogs were Created with IS mg (1.2S mg/kg) of

prednisone fbb] orally once daily for 3 weeks.

Treatment was initiated

one to two weeks after their last biopsy sample and given to 3 dogs at
one time.

After 52 hours and 3 weeks,

15 ml of whole blood was drawn

from the jugular vein and mixed with 2 ml of CPD-A1 and stored at 4C
until assayed 24 and 72 hours later.

An Intravenous glucose tolerance

test was administered on the same day as the 3 week sampling for
insulin receptors and parameters evaluated as described previously.
Identical parameters were measured from the Scatchard analysis of each
sample as described previously.
Data from the glucose tolerance tests and the erythrocyte insulin
receptor binding studies taken before and after prednisone
administration were compared by the Student's paired t test.
Differences were considered significant when

p < 0.05.

RESULTS

I.

INSULIN BINDING ASSAY TECHNIQUES

A.

INSULIN RECEPTORS OF LIVER MEMBRANES

1.

COMPOSITION OF LIVER MEMBRANE HOMOGENATE- Protein concentrations

of the liver membrane homogenates ranged from 100-600 ug/lOOul.
Electron microscopic evaluation of the liver membrane homogenate
pellets showed no Intact organelles

^Figure 4].

predominantly of disrupted membrane segments.

Matter consisted
Differentiation between

plasmalemma and Internal membranes was not possible.

2.

EFFECTS OF pH, TIME AND WASHING ON BINDING- For each pH sample

undergoing either a single or double wash, counts per minute (CPM)
were

plotted against time TFigures 5 & 61.Binding

over

the first 60 minutes of incubation at

rapidly Increased

all p H ’s measured.

With a

single wash, binding at pH 7 did not reach equilibrium during the 4
hours of the experiment, while with a double wash, equilibrium
occurred at 3 hours.

At pH 7.4, binding equilibrium did not occur in

the single wash samples, while with a double wash, equilibrium
occurred at 3 hours.

At pH 7.6, Increasing binding tapered off at 3

and 4 hours with the single wash and equilibrium occurred at 3 hours
with the double w a s h .

Equilibrium was not achieved during the 4 hours

of the experiment in either the single wash or double wash samples at
pH

8

.

wash),

At 3 hours, binding was lowest at pH 7.0 (single and double
almost identical at pH 7.4 and pH 7.6 (single and double wash)
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Figure 4a.

Electron microscopy of liver membrane homogenate.
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Figure 4b.

Electron microscopy of liver membrane homogenate
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6
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Figure 5

120
TIME ( m l n u U s )

180

240

R a t e of b i n d i n g of m o n o i o d o [T YR - A 1 4 ] i n s u l i n to c a n i n e liver
m e m b r a n e s at v a r i o u s pH's - s i n g l e w a s h ( # d H = 8.0, O
= 7.6, A p H = 7.4, £ p H = 7.0).

6
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Ra te of b i n d i n g o f m o n o i o d o [T YR - A 1 4 ] in su l i n to c a n i n e
l i v e r m e m b r a n e s at v a ri o u s pH's - d o u b l e w a s h ( # d H = 8.0,
O pH = 7 . 6, A p H = 7.4, A p H = 7.0).
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and either slightly lower (double wash) or higher (single wash) at pH
8.0.

Based on these findings,

under the following conditions:

future binding studies were performed
1) Buffer L at pH 7.4, 2) Incubation

time of 3 hours, and 3) washing the homogenate pellet twice.

3.

EFFECTS OF TEMPERATURE ON BINDING- For each temperature sample,

CPM was plotted against time [Figure 7].

During the first 30 minutes,

binding occurred most rapidly at 37C, then 24C/15C and more slowly at
4C.

Equilibrium occurred at 3 hours at all temperatures.

Binding at

4C occurred more slowly than the higher temperatures but was equal to
binding at 24c by 3 hours.

Binding at 150 and 37C was the same at

equilibrium and higher than binding at 4C and 240.

Based on these

findings, future binding studies were performed at 15C.

4.

SATURABILITY- The bound radioligand [*HR] was plotted against the

free radiogland [*H] at radioligand concentrations ranging from 0.5 to
500 ng/ml.

The specific binding data was generated by subtracting

non-specific binding from total binding.
shown In Figure

8

.

The resulting curves are

Total binding and non-specific binding curves

continued to increase In a linear manner with Increasing
concentrations of radioligand.

The specific binding curve began to

plateau at radioligand concentrations > 50 ng/ml.

Although an

absolutely horizontal portion of the hyperbola was never achieved at
the concentrations examined, the observed shape of the curve suggested
that saturation would occur if greater concentrations of radioligand
had been employed.

To confirm this, a double reciprocal plot of

l/bound insulin versus l/free insulin was constructed.

Linear
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regression analysis of these points yielded a y— intercept » 0.1311 and
an x-intercept “ -0.0054,

supporting the theory that binding sites

were finite and saturable [Figure 9].
5.

SPECIFICITY OF BINDING- The effects of various hormones on

binding of porcine monoiodo [TYR-A14] insulin to liver membrane
homogentate Is shown in Figure 10.

The percentage of hormone bound

for each of 4 hormones studied.

Unlabeled porcine insulin resulted in

a competitive— Inhibition curve.

The mean concentration of insulin

that inhibited the binding of the radioligand by SOX (EC^q ) was
45ng/ml.

The mean EC^ q for porcine prolnsulln was 300 ng/ml.

Glucagon and porcine desoctapeptlde insulin did not compete
appreciably with the radioligand for binding on the liver membrane
homogenate, even at concentrations greater

6

.

1000

ng/ml.

RATE OF DISSOCIATION- The radioligand bound, shown as percentage

of initial binding, was plotted against time [Figure 11].

Nonspecific

binding (tube 3) ranged from 231 to 32X of total binding.

Following

indefinite dilution,
dilution),
minutes,

dissociation occurred rapidly in tube

2

(infinite

binding unexpectedly Increased slightly for the first 15

then rapidly decreased in parallel to tube 2.

At the

initiation of dissociation, a great deal of vortexing was required to
resuspend the liver membranes into solution.

While vortexlng was done

in an ice bath, sufficient heat may have been generated to encourage
association, in spite of dilution with buffer, and this may have
accounted for the Increased binding noted initially.

Twenty-two

percent of the binding activity had dissociated by 60 minutes in tube
1 and 421 of the binding activity had dissociated by 60 minutes in

100
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w i t h i n su l i n r e c e p t o r s of c a n i n e live r m e m b r a n e s
( A G l u c a g o n , A Porcine DesoctapeDtide , O P o r c i n e Proinsulin,
# P o r c i n e Insulin).
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tube 2.

By 3 hours,

decrease In tube 2.

there was a 38 X decrease in tube

1

and 62JE

In tube 2, empty receptors are filled with the

excess unlabeled Insulin decreasing overall affinity and accelerating
the rate of dissociation.

The binding characteristic supports the

phenomenon of negative cooperativlty [Gammeltoft, 1984; Limblrd,
1986].

7.

SCATCHARD ANALSYIS- The total number of binding sites was

determined by the Rosenthal variation of the Scatchard analysis plot
[Limblrd, 1986].
10,000

Radioactivity measured in the sample containing

ng/ml of unlabeled porcine insulin was considered nonspecific

binding (NSB) and was subtracted from all other samples to obtain
specific binding for each concentration.

Maximum binding was the

radioactivity measured in the sample with no unlabeled porcine
Insulin.

The ratio of bound to free radioligand was plotted against

the concentration of Insulin bound (ng/ml) [Figure 12].

The resulting

curve was curvilinear in nature with an upward concave configuration.
When this curve was extrapolated to Its intersecting point on the
abscissa the total number of receptor sites (Ro) was obtained.

High

affinity and low affinity K^'s were obtained by taking this negative
Inverse of the slopes of the high affinity (vertical) and low affinity
(horizontal) portions of the curvilinear line.
Tables 3A & B.

Results are listed in

2
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R o s e n t h a l / S c a t c h a r d Plot of c a ni n e l i v e r m e m b r a n e i nsu lin
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a.

INTERASSAY COEFFICIENT OF VARIATION FOR INSULIN RECEPTOR

BINDING TO CANINE LIVER MEMBRANES- Interassay coefficient of variation
(CV) for X maximum binding was 25.OX when the assays were performed at
15C, pH 7.4 and Incubated for 3 hours.
binding waB 3.87 + 0.43.

The mean + SEM

The Interassay CV for

X

X

maximum

maximum binding was

26.IX when the assays were performed at 24C, pH 7.4 and incubated for
3 hours.

8

.

The mean + SEM X maximum binding was 2.56 + 0.30.

AVERAGE AFFINITY PROFILE- The data obtained from the Scatchard

plot was assigned to obtain the average affinity profile according to
the method of DeMeyts [Figure 13].

9.

Results are listed in Table 3B.

RADIOLIGAND DEGRADATION- Degradation of the monoiodo [TYR-A14]

Insulin was less than 5X in all cases.

The X degradation was used to

obtain a corrected total count for calculation of percentage of
specific binding for each Individual assay.

B.

INSULIN RECEPTORS OF CANINE ERYTHROCYTES

1.

ERYTHROCYTE COUNTS- Approximately 4.0 - 6.0 X 109 cells/ml were

counted In all assays.

More than 98X of the cells were viable, as

determined by the trypan dye exclusion technique [Gambhlr, et al,
1978).

Reticulocyte counts were estimated to be less than 5/500 cells

counted.
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2.

EFFECTS OF pH, TIME AND INCUBATION TEMPERATURE ON BINDINGa.

VARIATION IN TEMPERATURE- Binding (measured by CPM In the

erythrocyte pellet) at all temperatures reached binding equilibrium by

3 to 4 hours [Figure 14].

Binding was highest at 37C; however,

hemolysis was noted, as evidenced by a red discoloration of the
supernatant, after 45 minutes of Incubation.
in the 24C, 4C and 15C tubes in that order.

Binding was next highest
Hemolysis was noted In

the 24c tubwe after 2 hours of incubation and in the 15C tube after 3
h ours.
b.

VARIATION IN pH AND INCUBATION TEMPERATURE-

1.

EXPERIMENT 1- Binding at pH 8.0, 4C reached an equilibrium

at 4 hours and was the highest of all groups [Figure 15].

Binding at

pH 7.6, 4C was next highest and reached equilibrium after 2 hours.
Binding at pH 8.0,

15C was highest at 2 hours and declined afterwards.

Hemolysis was noted after 4 hours.
lowest and reached equilibrium at
2.
4C,

Binding at pH 7.6, 15C was the
2

hours.

EXPERIMENT 2- Binding was highest In samples

Incubated at

with the pH 8.0 sample being slightly higher than the pH 7.6

sample [Figure 16].

At 1 5C maximum binding was highest at pH 7.6 and

was similar to the 4C, pH 7.6 sample.

At 24C maximum binding was at

pH 8.0; however, hemolysis occurred.

3.

SATURABILITY- The bound radioligand [*HR] was plotted against

free radioligand [*H] at radioligand concentrations ranging from 0.5
to 500 ng/ml.

The specific binding was generated by subtracting non

specific binding from total binding.
In Figure 17.

The resulting curves are shown

Total binding and non-specific binding continued to
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Increase In a linear manner with Increasing concentrations of
radioligand.

The specific binding curve began to plateau at

radioligand concentrations > 50 ng/ml.

Although an absolutely

horizontal portion of the hyberbola was never achieved at the
concentrations examined* the observed shape of the curve suggested
that saturation would occur If greater concentrations of radioligand
had been employed.

To confirm this* a double reciprocal plot of

1/bound Insulin versus 1/free Insulin constructed.

Linear regression

analysis of these points yielded a y-lntercept ” 0.0461 and x—
Intercept " -0.0051*
finite and saturable

4.

supporting the theory that binding slteB were
[Figure 18 ].

SPECIFICITY OF BINDING- The effects of various hormones on

binding of porcine monolodo [TYR-A14]
In Figure 19.

Insulin to erythrocytes Is shown

The percentage of specific binding was plotted against

the concentration of hormone bound for each of 4 hormones studied.
Unlabeled porcine Insulin resulted in a typical competltlve-lnhibltlon
curve.

The mean EC^q for porcine Insulin was 10 ng/ml.

for porcine prolnsulln was 200 ng/ml.

The mean EC^q

Glucagon and porcine

deaoctapeptlde on erythrocytes, even at a concentration of

5.

1000

ng/ml.

DISSOCIATION OF BINDING- The radioligand binding* shown as

percentage of Initial binding* was plotted against time [Figure 20].
Non-specific binding (tube 3) stayed between 10-15Z of total binding
at all times.

Following Infinite dilution* dissociation occurred

rapidly In both tube

1

(Infinite dilution) and tube

dilution plus excess unlabeled Insulin).

2

(Infinite

Forty— three percent of the
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binding activity had dissociated by 1 hour In tube 1 and 56% In tube
2.

By 4 hours,

59X

and 82t of binding activity had dissociated In

tubes 1 and 2 respectively.

In this experiment, an accelerated rate

of dissociation was observed In tube

6

.

2

with excess Insulin.

SCATCHARD ANALYSIS- The determination of total number of receptor

sites and K^'s for canine erythrocyte Insulin receptors were done by
the method described under Scatchard analysis for canine liver
membranes [Figure 21].

a.

Results are listed In Tables

6A

& B.

INTERASSAY COEFFICIENT OF VARIATION FOR INSULIN RECEPTOR

BINDING TO CANINE ERYTHROCYTES- The interassay coefficient of
variation (CV) for

X

maximum binding for the 3 day comparison at pH

7.6. was 4.89 w i t h a m e a n + S E M of 7.12

X

0.20.

The I n t e r a s s a y CV for

maximum binding for the 3 day comparison at pH 8.0 was 8.27 with a

mean + SEM of 8.49 + 0.41.

The Interassay CV for

X

maximum binding

for the 5 day comparison at pH 7.6 was 9.34 with a mean + SEM of 4.35
+ 0.18.
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7.

AVERAGE AFFINITY PROFILE— The data obtained from the Scatchard

plot was analyzed to obtain the average affinity profile by the method
of DeMeyts

[DeMeyts & Roth, 1975]

listed In Table

8

.

[Figures 22 & 23].

Results are

6 B.

RADIOLIGAND DEGRADATION— Degradation of monolodo [TYR—A 1A ]

Insulin during the assay was less than 5X in all c a s u . „ The
percentage of degradation was used to obtain a corrected total count
for each Individual assay.

9 1
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II.

INSULIN RECEPTOR BINDING PARAMETERS OF LIVER MEMBRANES AND

ERYTHROCYTES FROM A SAMPLE CANINE POPULATION.

A.

LIVER MEMBRANES- Within liver membrane data taken from 3

replicates for

12

dogs, there was a strong correlation between the

total number of receptor binding sites and the low-affinity
11.

rTable

There was also a high correlation between the percentage of

maximum binding and the number of high-affinity receptor binding
sites.

Ke correlated with both the percentage of maximum binding and

the number of high-affinity binding sites.
There was a moderate inverse correlation between Ke and both the
low-affinity K^ and the total number of receptor binding sites.

There

was some inverse correlation between the percentage of maximum binding
and the high-affInity K^.

B.

ERYTHROCYTES- Within erythrocyte data taken from 3 replicates for

12

dogs, there was a moderate correlation between the total number of

receptor binding sites and the low-affinity Kp as well as between the
number of high-affinity binding sites and high-affinity

rTable

2

’.

The percentage of maximum binding correlated with both the number of
high-affinity receptor binding sites and K e .
There was an inverse relationship between the percentage of
maximum binding and the high-affinity

.

Ke correlated inversely

with both the total number of receptor binding sites and the
high-affinity Kp.

Table 1.

Correlation Coefficients for Insulin Binding Parameters of Canine Liver Membranes

Comparison

r ^

Prob(r

Total Number of Binding Sites

vs

Low-Affinity

0.83L90

0.0001

X Maximum Binding

vs

Number of High-Affinity Sites

0.74750

0.0001

%

vs

Ke

0.50752

0.0016

Number of High-Affinity Binding Sites

vs

Ke

0.40858

0.0001

Low-Affinity

vs

Ke

-0.66350

0.0001

Total Number of Binding Sites

vs

Ke

-0.65383

0.0001

X

vs

High-Affinity

-0.39216

0.0180

Maximum Binding

Maximum Binding

Table 2.

Correlation Coefficients for Insulin Binding Parameters of Canine Erythrocytes

Comparison
r ,0 bs
*■--------------------------------------------

Prob(r)|r
, |/H O :f-0)
' ' 0bs'

Total Number of Binding Sites

vs

Low-Affinity

0.62057

0.0001

Number of High-Affinity Binding Sites

vs

High-Affinity K^

0.51170

0.0014

Number of High-Affinity Binding Sites

vs

X

0.34318

0.0404

1

Maximum Binding

vs

Ke

0.31770

0.0590

X

Maximum Binding

vs

High-Affinity Kp

-0.46602

0.0042

Total Number of Binding Sites

vs

Ke

-0.44171

0.0070

High-Affinity K^

vs

Ke

-0.31322

0.0629

Maximum Binding

vO
Ln
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C.

VARIATION IN INSULIN BINDING PARAMETERS IN A NORMAL CANINE

POPULATION

1.

LIVER MEMBRANES- Each binding parameter was evaluated by

performing an analysis of variance on 3 replicate samples for each of
the 12 dogs.

For the liver membranes, there was no significant

variation among the 12 dogs for any of the parameters evaluated (Prob
(a greater F)

>0.05)

[Tables 3A, 3B & 4],

The difference among the

total receptor site values for male dogs approached significance (Prob
(a greater F) " 0.0582).
The coefficient of variation (CV) was high for "within dog" and
"among dog" sampling for liver membranes (Table 5),

The lowest CVs

were In the % maximum binding (29.7-38.4%), high-affinity
(16.6-26.0%)

2.

and the number of high-affinity (25.0-31.1%).

ERYTHROCYTES- For the erythrocytes,

higher variation among the

12

there were significantly

dogs than a pooled value representing

"within dog" variation, for the percentage of maximum binding and the
number of high-affinity receptor binding sites [Tables
The variations among the high-affinity

6 A,

6B

& 71.

values for the 12 dogs

approached significance (Prob (a greater F) “ 0.0523).

When an

analysis of variance was performed on only the male dogs, there was no
significantly greater variation among the
value representing "within dog" variation.

6

male dogs than a pooled
When an analysis of

variance was performed on only the female dogs there was a
significantly higher variation among the female dogs than a pooled
value representing "within dog" variation, for the % maximum binding

Table 3A.

Insulin Receptor Binding Parameters for Liver Membranes from 12 Dogs

%
Dogs
Replicates
Males
3

Total Number of Receptor
Sltes/pg Protein

Maximum Binding
A

10.8

B

C

A

B

C

10.4

10.3

156

250

High-Affinity Receptor
Sites/pg Protein
A

B

C

216

73

69

63

5

9.1

6.1

7.2

490

470

165

74

54

44

6

8.7

12.1

12.8

147

229

312

61

90

90

9

7.8

1 1.1

20.4

284

149

453

71

81

101

10

7.0

11.6

12.8

377

597

488

47

90

69

11

7.6

9.5

15.3

136

162

152

36

103

116
74

298

10.5

X
Females
1

7.1

6.8

8.4

143

359

177

61

51

53

2

10.4

9.8

8.3

190

127

154

72

73

61

4

8.4

4.8

7.4

316

213

413

90

70

62

7

7.5

6.3

20.5

429

321

229

59

65

125

8

9.2

11.9

9.8

207

629

121

76

117

90

12

9.2

9.9

15.0

319

394

494

78

105

107

X

9.5

291

79

Table 3B.

Insulin Receptor Binding Parameters for Liver Membranes from 12 Dogs

Low Affinity K^, NM

High Affinity K^, NM/100

Ke, NM-1

Dogs
Replicates
Males
3

A

B

C

A

B

C

A

B

C

0.395

0.714

1.044

5.590

5.600

6.050

1.073

0.539

0.540

5

1.970

2.703

0.605

4.960

6.680

4.960

0.310

0.183

0.521

6

0.323

0.499

0.713

5.710

6.170

6.470

0.936

0.718

0.480

9

1.157

0.340

1.372

7.198

8.690

3.317

0.366

0.731

0.756

10

1.155

3.338

0.775

4.735

5,162

2.694

0.233

0.329

0.464

11

0.347

0.300

0.116

5.347

7.079

4.306

0.608

0.926

1.675

X

5.584

1.070

0.633

Females
1

0.410

0.573

0.595

5.780

5.190

5.460

0.747

0.275

0.567

2

0.447

0.221

0.516

4.860

5.840

6.130

0.867

1.048

0.629

4

1.076

0.644

2.114

6.770

6.860

5.990

0.484

0.457

0.271

7

1.308

2,203

0.343

5.639

7.224

4.381

0.224

0.241

1.324

8

0.685

2.665

0.220

6.662

9.119

7.366

0.562

0.224

1.028

12

1.246

1.072

00

7.246

7.179

4.735

0.368

0.382

0.471

X

1.005

6.243

0.565

Table 4.

Analysis of Variance of Insulin Receptor Binding Parameters from Liver Membranes of 12 Dogs*

^Maximum
Binding

Male Dogs
MS Within Dogs
MS Among Dogs
r

MS Among
* MS Within

Prob (a greater F)
Female Dogs
MS Within Dogs
MS Among Dogs

Total Number of
Receptor Sites
/pg Protein

High Affinity
Receptor Sites
/pg Protein

Low Affinity
V

m

High Affinity
Kjj, NM/100

Ke, NM-1

13,487
39,714

513
364

0.714
0.910

2.109
1.747

0.090
0.226

0.75

2.94

0.71

1.27

0.83

2.52

0.6011

0.0582

0.6280

0.3367

0.5534

0.0882

19,358
22,257

385
762

0.547
0.547

1.070
2.098

0.113
0.081

13.013
9.772

13.232
11.440

r ^ MS Among
" MS Within

0.86

1.15

1.98

1.00

1.96

0.72

Prob (a greater F)

0.5321

0.3874

0.1542

0.4578

0.1574

0.6235

16,422
30,985

449
563

0.630
0.728

1.590
1.923

0.101

0.81

1.89

1.25

1.16

1.21

1.51

0.6233

0.0983

0.3091

0.3655

0.3337

0.1951

Overall
MS Within Dogs
MS Among Dogs
MS Among
* MS Within
Prob (a greater F)

13.123
10.606

* 6 males, 6 females, each dog sampled 3 times;
** MS = mean square

0.153

Table 5.

Coefficients of Variation (CV) for Insulin Receptor Binding Parameters for Liver Membranes of 12
Dogs*

ZMaximum
Binding

Total Number of
Receptor Sites
/pg Protein

High Affinity
Receptor Sites
/pg Protein

Low
Affinity

V

“*

High
Affinity
NM

Ke, NM-1

100

Male Does
Within Dog
Among Dog

34.3
29.7

39.0
67.0

30.6
25.8

79.0
89.1

26.0
23.7

47.3
75.0

Female Does
Within Dog
Among Dog

38.4
35.7

47.8
51.3

25.0
35.1

73.6
74.0

16.6
23.2

59.5
50.3

Overall
Within Dog
Among Dog

36.2
32.6

43.6
59.9

27.8
31.1

76.5
82.2

21.3
16.9

53.1
65.3

males, 6 females, all dogs sampled 3 times.
Expressed as %.
*6

Table 6A.

Insulin Receptor Binding Parameters for Erythrocytes from 12 Dogs

X
Dogs
Replicates
Males
3
5
6
9
10
11
X

Total Number of Receptor
Sltes/RBC

Maximum Binding

A

B

C

A

B

C

7.1
3.7
3.2
A.5
6.8
6.6

A.8
A.2
5.6
3.8
5.3
A.8

7.2
6.7
5.0
A.7
5.8
5.8
5.3

119
18A
110
303
86
158

206
193
250
70
15A
375

3.5
A.2
6.2
3.0
7.0
2.8

5.5
2.6
A. 1
3.A
7.1
5.0

8.5
A.8
6.1
5.2
9.5
3.7
5.1

205
170
All
291
529
332

220
37
238
128
166
155

High-Affinity Receptor
Sltes/RBC
A

B

C

355
127
274
176
131
101
*187

21
25
20
23
33
A9

29
22
30
24
47
27

30
20
35
27
32
39
29

162
5AA
AA3
57
3A5
23A
*259

15
1A
27
26
41
A3

23
15
18
29
39
30

32
20
32
21
AA
55
29

Females
1
2
4
7
8
12
X

* p = 0.0779
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Table 6B.

Insulin Receptor Binding Parameters for Erythrocytes from 12 Dogs

Low Affinity

NM

High Affinity 1^, NM/100

Ke. NM-1

Dogs
Replicates
Males
3

A

B

C

A

B

C

A

B

C

0.954

1.404

1.955

3.208

3.868

3.074

0.532

0.509

0.284

5

2.385

0.994

1.994

5.350

3.950

2.398

0.315

0.405

0.597

6

1.279

1.228

1.850

4.836

3.853

6.168

0.416

0.667

0.409

9

1.066

0.444

1.480

2.752

4.427

4.092

0.423

0.792

0.447

10

0.456

1.464

0.454

2.561

6.433

3.289

1.439

0.529

0.733

11

1.008

4.793

0.427

4.135

4.621

5.461

0.812

0.308

0.640

X

4.137

1.424

0.570

Females
1

4.104

2.443

1.016

4.040

3.606

2.722

0.181

0.442

0.847

2

3.413

0.340

5.809

4.330

5.185

2.471

0.231

0.957

0.116

4

7.348

5.917

2.584

3.540

3.171

3.907

0.342

1.561

0.189

7

2.439

0.792

0.430

3.986

6.547

2.954

0.180

0.341

1.186

8

1.877

0.926

2.775

2.859

4.469

3.510

0.438

0.572

1.105

12

1.452

0.763

2.087

7.428

4.885

11.417

0.181

0.438

0.262

2.584

4.501

0.531
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Table 7.

Analysis of Variance of Insulin Recepter Binding Parameters from Erythrocytes of 12 Dogs*

ZMaximum
Binding

Total Number of
Receptor Sites
/pg Protein

High Affinity
Receptor Sites
/pg Protein

Low Affinity

High Affinity
K^, NM/100

Ke, NM" 1

Male Dogs
MS Within Dogs
MS Among Dogs
MS Among
” MS Within

1.281
2.074
1.62

9835
4287
0.44

47
134
2.83

1.185
0.687
0.58

1.530
1.079
0.71

0.066
0.089
1.35

Prob (a greater F)

0.2285

0.8152

0.0648

0.7158

0.6307

0.3103

Female Dogs
MS Within Dogs
MS Among Dogs

2.296
7.651

22,896
19,890

3.513
3.38

3.053
6.815

2.905
8.811

0,220

3.33

0.87

6.63

2.23

3.03

0.35

Prob (a greater F)

0.0406***

0.5296

0.0035***

0.1181

0.0535

0.8756

Overall
MS Within Dogs
MS Among Dogs

1.788
4.862

16,366
12,089

49
236

2.120

3.751

2.218
4.945

0.143
0.083

2.72

0.74

4.80

1.77

2.23

0.58

0.0217***

0.6823

0.0008***

0.1220

0.0523

0.8165

MS Among
= MS Within

MS Among
MS Within
Prob (a greater F)

103

* 6 males, 6 females, each dog sampled 3 times;
** MS - mean square
***Significant

0.076
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and the number of high— affinity binding sites.

The differences among

the total receptor site values for females approached significance
(Prob (a greater F) - 0.0535).

These findings would suggest that

there was more variation among females than among males.
In addition, mean squares of each binding parameter for males and
females were compared.

Results of this analysis of variance showed

that there was a greater "among dogs" variation in females compared to
"among dogs" variation in males that was significant for low-affinity
and high-affinity

far erythrocytes.

The CVs were high for both "within dog" and "among dog" sampling
of erythrocytes [Table 81.

The lowest CVs were in the

X

maximum

binding (21.3 - 54.0%), the number of high affinity receptor sites
(23.0 - 63.7%) and the high—affinity

(25,1 — 66.0%).

CVs occurred in female dogs as compared to male dogs.
mentioned,

The higher
As previously

the difference In variation was significant for "among

dogs" for the overall population as well as for females for the %
maximum binding and the high-affinity binding sites.

The variation

occurring "within dogs" was less than the variation "among dogs".

D.

THE EFFECTS OF SEX ON INSULIN RECEPTOR BINDING PARAMETERS

When Insulin receptor binding parameters for liver membranes were
compared according to sex by an unpaired t test, there were no
significant differences between males and females for any of the
parameters [Tables 3A, 3B &4],

Table 8.

Coefficients of Variation (CV) for Insulin Receptor Binding Parameters for Erythrocytes of 12
Dogs*

XMaximum
Binding

Total Number of
Receptor Sites
/RBC

High Affinity
Receptor Sites
/RBC

Lov
Affinity

V

U

^

Male Dogs
Within Dog
Among Dog

21.3
27.1

53.0
35.0

23.5
39.5

76.5
58.2

Female Dogs
Within Dog
Among Dog

29.6
54.0

58.4
54.5

24.7
63.7

Overall
Within Dog
Among Dog

25.6
29.5

57.4
49.3

24.1
53.0

72.7
96.8

males, 6 females, all dogs sampled 3 times.
Expressed as X.

*6

High
Affinity

V

™

Ke, NM" 1

100

29.9
25.1

45.2
52.4

67.6

37.9

101.0

66.0

88.3
51.9

34.5
51.5

68.7
52.2
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When erythrocyte binding parameters were compared according to
sex by an unpaired t test, no significant differences between males
and females were observed [Tables 3A, 3B &4].

Insignificant Increases

in the total number of binding sites ( p - 0.0779), low-affinity
■

0

.1 2 2 ) and high-affinity

(p

Cp “ 0.640) were observed for females.

As previously mentioned CVs for both "within dog" and "among dog"
comparisons were high for both liver membranes and erythrocytes
[Tables 5 &

8

].

This degree of variation might have masked the

presence of significant differences in binding parameters between the
sexes.

E.

LIVER MEMBRANES VERSUS ERYTHROCYTES - Insulin receptor binding

parameters of liver membranes and erythrocytes were compared by
Pearson's correlation coefficient.

There was no significant

correlation between the percentage of maximum binding,

the total

number or the number of high-affinity binding sites, low or
high-affinity

or Ke, when all 12 dogs were compared.

The same was

true when male dogs were compared; however, when female dogs were
compared,

there was a correlation between liver membrane and

erythrocyte Ke values (r " 0.47610, p “ 0.0458).
As previously mentioned, CVs for both "within dogs" and "among
dog" comparisons were high for both liver membranes and erythrocytes
[Tables 5 & 81.

This degree of variation might have masked the

presence of significant correlations.
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F.THE EFFECTS

In 9

OF ANESTHESIA ON ERYTHROCYTE

dogs, erythrocyte Insulin receptor

prior to anesthesia [Table 9].

INSULIN RECEPTOR BINDING

binding was measured

When compared to samples taken during

anesthesia, by a paired t test, the percentage of maximum binding was
significantly Increased from a mean of 3.96 to 5.28 ( p * 0,028),
There were insignificant increases in the total number and
high-affinity receptor sites ( p - 0.1780 total sites;
high-affinity sites).
indicated
In

p - 0.1037

An insignificant decrease in affinity, as

by an Increase In the low-affinity value and a decrease

the Ke value was observed ( P “ 0,306 low-affinity K^;

p = 0.260

Ke) .

III.

THE EFFECTS OF GLUCOCORTICOIDS ON GLUCOSE TOLERANCE, INSULIN

SECRETION AND ERYTHROCYTE INSULIN RECEPTOR BINDING IN

6

MALE BEAGLE

DOGS

A.

GLUCOSE TOLERANCE- The effect of prednisone administration on

glucose response to 500 mg of intravenous gtucose/kg of body weight
is shown in Figure 24 and Table 10,

Mean serum glucose concentration

in fasting dogs was insignificantly increased after prednisone
administration for 3 weeks (0.10>

P >0,05).

There was an increase

in mean serum glucose concentrations at 5, 10, 15, 25, 35, 45 and 60
minutes after glucose administration; however, the Increases were not
significant ( p > 0.10).

Mean disappearance rate (K) was not different

after prednisone administration.

Table 9.

Dog

The Effects of Anesthesia On Erythrocyte Insulin Receptor Binding

Replicate

XMaximum
Binding

Total Number of
Receptor Sites
Per RBC

High-Affinity
Receptor Sites
Per RBC

Low-Affinity
Kj,. NM

High-Affinity
K^, NM/100

Ke, NM-1

Before

During

Before

During

Before

During

Before

During Before During Before During

4

C

2.24

6.09

14

443

14

31

0.072

2.594

7.237

3,907

1.608

0.189

5

C

4.09

6.73

164

127

18

20

2.711

1.994

4.310

2.398

.239

0.597

6

C

3.23

4.98

98

274

24

35

0.699

1.850

4.938

6.168

.482

0.409

7

B

3.59

3.44

17

128

17

29

0.040

0.792

3.955

6.547

2.689

0.341

8

B

7.03

7.07

111

166

36

39

0.184

0.926

3.335

4.469

.840

0.572

9

B

4.61

3.81

161

70

23

24

0.548

0.444

2.843

4.427

.450

0.792

10

C

5.02

5.83

109

131

50

32

0.488

0.454

7.957

3.289

.557

0.733

11

C

4.U

5.85

69

101

15

39

0.439

0.427

2.803

5.461

.863

0.640

12

C

1.72

3.71

247

234

22

55

2.950

2.087

7.966 11.417

.133

0.262

3.96**
0.52

5.28**
0.45

110

186
39

24
4

34
3

0.903
0.372

1.285
0.281

5.038
0.711

0.873
0.269

0.504
0.071

Mean
SE

25

5.343
0.879

*A11 values obtained from sample taken during anesthesia represent the mean of 2 duplicate assays.
IOB

**P < 0.05
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BLOOD GLUCOSE

m g /dl

300

200

100

20

30

40

50

60

TIME ( m l n u t a s )

F i g u r e 24.

S e r u m g l u c o s e c o n c e n t r a t i o n s in 6 m a l e b e a g l e s , b e f o r e and
a f t e r a d m i n i s t r a t i o n of 1.5 mg p r e d n i s o n e / k g o r a l l y each
d a y for 3 w e e k s , d u r i n g IV q l u c o s e t o l e r a n c e tests (500
m g / k g gl uc o s e ) (Mean + SEM, mg/dl , # B e f o r e T r e a t m e n t ,
O After Treatment).
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Table 10.

Effects of Prednisone on Glucose Concentrations During an
IV Glucose Tolerance Test In 6 Male Beagle Dogs.

Dog No.

Fasting Glucose mg/dl
Before
After

Clearance Rate (X/mln)
Before
After

1

104

2.89

2

99

3.55

**3

108

4

93

**5

96

102

2.20

2.44

**6

104

105

2.74

2.39

120

2.61

2.26

3.09

7

81

2.38

8

76

2.59

**9

84

86

3.64

3.16

**10

73

94

6.25

2.82

**H

68

103

2.69

2.50

12

62

X

3.26

+ SEM

N - 12
N *

* P

6

<

3.16+0.31

87 .3±4.5
treated
males

0.10

** Males

8 8

.8 ± 6 .7*

101.7+4.7*

3.36+0.61

2.60+0.14
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B.

INSULIN SECRETION- The effect of prednisone administration on

insulin secretion in response to 500 mg of Intravenous glucose/kg of
body weight is shown in Figure 25 and Table 11.
concentrations in

Mean serum insulin

fasting dogs was not significantly different after

prednisone administration compared to before treatment in the
dogs.

6

male

The Insulin peak response (IPR), total insulin secretion (TIS)

and lnsullnogenic index (AI/AG) did not show a difference with
prednisone treatment.

Mean Insulin concentrations at 5, 10, 15, 25,

35, 45, and 60 minutes after glucose administration were not
significantly different after the administration of prednisone.

C.

BODY WEIGHT - The effect of prednisone administration on body

weight is shown in Table 12.

There was a significant ( p < 0 . 0 0

decrease in mean body weight after 3 weeks of prednisone
administration when the amount of dog food fed and consumed was kept
exactly the same.

All dogs lost weight and that weight lost ranged

from 0.4 to 1.8 kg/dog.

Six females who were not given prednisone

were also evaluated for changes in weight during this period.

There

was not a significant change in body weight for this group of dogs.

D.

INSULIN RECEPTORS— Insulin receptors binding parameters of canine

erthyrocytes that were measured 52 hours and 3 weeks after the onset
of daily prednisone administration were compared to unanesthetized
samples taken prior to administration of prednisone f5C,

6C

, 9B, 10C

1 L2

60

B e f o r e Rx
A f t e r Rx

50

40

iui/mf
r NnnsNi

30

20

10

10

20

30

40

50

60

TIME ( m i n u t e s )

F i g u r e 25.

S e ru m i n su l i n c o n c e n t r a t i o n s in
and a f t e r a d m i n i s t r a t i o n of 1.5
each day for 3 w e e k s , d u r i n q IV
(500 m g / k g gl uc o s e ) (Mean ± SEM
Treatment, O A f t e r Treatment).

6 male beagles, before
mg p r e d n i s o n e / k g o r a l l y
g l u c o s e t o l e r a n c e tests
, ulU/ml , # B e f o r e

1 13

Table LI.

Effects of Prednisone on Insulin Secretion During an IV
Glucose Tolerance Test In 6 Male Beagle Dogs.

Insulin in
Fasting Dogs
Dog No.
( IU/rol)
Before
Af ter

Insulin
Peak Response
( IU/ml)
After
Before

Total Insulin
Secretion
( IU/ml/min)
Before After

Insullnogenlc
Index
______________
Before Af te

1

5.4

62.8

216.3

0.325

2

6.6

67.8

209.9

0.353

**3

7.7

4

5.1

**5

12.0

6.6

20.5

13.7

71.5

**6

12.0

12.1

54.3

46.4

155.5

7.5

43.9

11.9

132.3

39.6

72.2

24.9

0.252

0.062

0.126
66.0

0.099

0.062

152. 7

0.289

0.230

7

4.9

72.2

228.6

0.363

8

5.6

22.5

67.5

0. 114

**9

4.7

8.0

33.4

38.3

122. 7

109.5

0.118

0.191

**10

8.5

13.9

41.4

41.5

123.2

108.4

0.290

0.284

**11

12.1

11.0

30.3

79.3

111.7

266.9

0. 159

0.493

12

3.5

X+l

15.4

133.8

0.249

40.8±
5.6

137.0+
16.2

0.228±
0.029

SEM

N-12

7.3+0.9

N-6
treated

9.5 + 1.2

males

**Males

9.9 +
1.2

37.3+
4.8

38.9+
10.2

119.5±
11.3

3.9± 0 .2 0 1 +
32.8 0.035

12

.2 2 0 :
0.066
0
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Table 12.

Effects of Prednisone on Body Weight of 6 Male Beagle Dogs
Compared to 6 Untreated Female Dogs During the Same Time
Period.
____________Body Weight, Kg_____________
Before
After

Dog No.

1

11. I

11.4

2

10.5

10.5

**3

11.1

10.0

4

11.1

11.8

**5

12.0

10.7

**6

12.3

10.5

7

11.8

11.6

8

12.3

11.1

**9

12.7

12.3

**10

12.7

11.6

**11

14.1

13.0

12

11.4

10.9

X ± 1 SEM
N-12

11.9+0 .3

11.3+0.2

N -

6

females

11.4f0 .3

11.2+0.2

N -

6

treated males

12.5tO .4*

11.4+0.5*

*

p <

**Males

0.01
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and 11C; unanesthetized sample of 3C lost) by a paired t test (Table
13].

After 52 hourB, there was an Insignificant Increase In the

percentage of maximum binding from a mean of 4.2% to 6.45% (0.10 > P >
0.05).

There were Increases in the total number and high-affInity

receptor sites, although the increases were not significant (p >
0.10).

Slight changes In affinity were conflicting and not

significant (decreased affinity as evidenced by an Increase In
low-affinity K^ and an increased affinity as evidenced by an increase
In the Ke and a decrease in high-affinity K^)

(p

>0.10).

-

There were no significant changes in any binding parameters
measured after 3 weeks of prednisone administration.

There was an

insignificant increase in the total number of receptor sites and an
insignificant increase in the low-affinity K~ value ( p > 0 , 1 0 ).

Table 13a.

The Effects of Prednisone on Erythrocyte Insulin Receptor Binding in Male Dogs*
Total Number of
Receptor Sites
Per RBC

^Maximum
Binding

Dog
Before

3

52 HR

3 WKS

5.17

7.13

Before

High-Affinity
Receptor Sites
Per RBC

52 HR

3 WKS

43

63

Before

52 HR

3 WKS

23

33

5

4.09

4.06

3.10

164

55

127

18

16

27

6

3.23

3.14

3.57

98

330

286

24

24

13

9

4.61

8.28

7.20

161

135

149

23

33

40

10

5.02

9.35

3.77

109

357

51

50

54

17

11

4.11

7.43

3.50

69

56

119

15

38

18

N=6 X

6.24

4.71

162.7

132.5

31.3

24.4

SE

1.01

0.78

64.3

34.4

5.5

4.3

N=5 X

4.21**

6.45**

4.23

120 . 2

186.6

146.4

26.0

33.0

23.0

SE

0.30

1.21

0.75

18.4

65.7

38.5

6. 2

6.5

4.8

*A11 values expressed as mean of duplicate samples assayed. "Before" samples taken from unanesthetized
samples taken during main study. "52 HR" Samples taken 52 hours after the onset of administering
prednisone orally each day. "3 WKS" Samples taken 3 weeks after the onset of administering prednisone
orally each day.
0 ,1 0 .
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** p <

Table 13b.

The Effects of Prednisone on Erythrocyte Insulin Receptor Binding in Male Dogs*
Low Affinity

Dog

V
Before

3

High Affinity
Kp, NM/100

m

52 HR

3 WKS

0.330

0.431

Before

Ke, NM-1

52 HR

3 WKS

4.257

4.212

Before

52 HR

3 WKS

1.213

1.443

5

2.711

0.650

1.040

4.310

4.329

7.450

0.239

0.665

0.347

6

0.699

2.061

4.889

4.938

4.863

3.385

0.482

0.148

0.190

9

0.548

0.741

0.990

2.843

2.804

4.754

0.450

0.901

0.839

10

0.488

3.487

0.636

7.957

4.521

3.836

0.557

1.981

0.889

11

0.439

0.328

1.042

2.803

4.014

3.165

0.863

0.352

0.545

N=6 X

1.266

1.504

4.131

4.467

0.877

0.709

SE

0.516

0.684

0.290

0.640

0.270

0.184

N=5 X

0.977

1.453

1.719

4.570

4.106

4.518

0.518

0.809

0.562

SE

0.436

0.587

0.795

0.941

0.353

0.781

0.101

0.319

0.136

♦All values expressed as mean of duplicate samples assayed. "Before" samples taken from unanesthetized
samples taken during main study. "52 HR" Samples taken 52 hours after the onset of administering
prednisone orally each day. "3 WKS" Samples taken 3 weeks after the onset of administering prednisone
orally each day.

DISCUSSION

I.

ASSAY TECHNIQUES

The use of porcine Insulin (both labeled and unlabeled) Is Ideal
for studies In the dog since the amino acid sequence of insulin Is
Identical In these

2

species fGanong, 1985].

The fact that structure

is identical is very Important for immunoreactlvlty in the case of
radioimmunoassays [Relmers, et a l , 1982].

Structural similarity is

also of Importance for radlo-receptor Interactions as evidenced by
competitive-inhibition curves using insulin with similar but different
structures (prolnsulln, desoctapeptlde insulin, guinea pig insulin,
chicken insulin)

[Cambhir, et a l , 1978; Posner,

1974].

The decreased

binding by prolnsulln and desoctapeptlde insulin in
competitlve-inhibition curves In this study supports the importance of
structural similarity in radio-receptor studies fFigures

10

& 19].

Monoiodo[TYR-A14]insulin was used in this study due to its
previously described ideal bioactivity and binding affinity fFrank, £t
a l , 1983],
stable for

Even though this radioligand has been reported to be
6

months the radioligand was only used for a maximum of 3

months after preparation (stored at 4 C ) .

This decision was made due

to an observed irregularity in duplicate sample counts in assays
conducted using older radioligand and the reported concerns about
decreases in the apparent number of binding sites fMattinen, et a l ,
1984],
The conditions for assaying canine liver membrane insulin
receptors used were similar to previously reported conditions (buffer
118
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content* pH & temperature)

[Posner, 1974].

The assay conditions for

canine erythrocytes used varied significantly from assay conditions
Initially described fGatnbhlr, et al, 1978; Dleberg, et al, 1986] but
utilized a similar incubation temperature reported for erythrocyte
receptor assays [Pettersson, et a l , 1984].
The rationale for varying the previously described temperature
from ISC to 4C and the previously described pH from 8.0 to 7.6, was to
maximize binding while minimizing erythrocyte hemolysis.

Previous

studies have shown an increase in hemolysis of canine erythrocytes as
the pH was Increased [Glger, et a l , 1985],

The results of this study

showed that at 4 hours, hemolysis was not present at pH 7.6, whereas,
at pH 8.0 it routinely occurred TFigures 14-161.
Other studies have shown that the occurrence of hemolysis in
radioreceptor assays of erythrocytes may decrease binding by as much
as 25% [Simionescu, et al, 1985] .

In the present study, hemolysis

actually Increased binding when performed at 24C and 37C up to a
point.

This could have been due to binding by Intracellular receptors

or non-insulin receptor binding in hemolyzed samples.

After longer

hours, the binding in hemolyzed samples actually decreased at those
same incubation temperatures.

Binding decreased in all samples in

which hemolysis occurred at 15C.
The design utilized in this study was such that erythrocyte
assays were performed 16 and 64 hours after collection (stored at 4C).
While there was some variation in the results of the paired assays run
on each sample, there was no trend indicating an effect of storage on
assay binding parameters.

Gambhir, et a l , found that human

erythrocytes can be stored for up to 72 hours at 4C without changes in
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Insulin binding. Insulin receptor sites per cell or average affinity
constant of the empty

sites

[Gambhlr, et a l , 1983].

When Interassay coefficient of variation (CV) was determined in
the present study, assays were run on 5 consecutive days from a single
Bample of blood stored at 4C.

The CV was 9.3% for the 5

determinations and the variation showed no trend over time, supporting
the previous finding of a lack of effect of storage at AC on Insulin
binding after 72 hours (up to 96 hours In the present study).
Demonstration of receptor association, dissociation, saturabllity
and specificity supports that binding sites, observed In these
studies,

represent the physiological receptor for Insulin on canine

erythrocytes and liver membranes

[Llmblrd, 1986],

In addition, assay

precision was determined to assess the usefulness of these assays as
clinical research tools.

Precision in the erythrocyte assay was good

(interassay coefficient of variation “ 9.3%), whereas precision for
the liver membrane assay was not as good (interassay coefficient of
variation « 25.0%).
This lack of precision In the liver membrane assay could be
attributed to various assay techniques, Including the technique for
separating bound from free radioligand.

The double washing method

could have Introduced significant error In CPM's by disrupting binding
[Llmblrd,

1986].

The lack of precision makes this liver membrane

assay, using the technique described here, undesirable for research
and clinical purposes.
The Interpretation of the curvilinear nature of the Scatchard
plot is not as clear-cut as previously thought
1984; Sllberrlng & Wallgorskl,

1985; Llmblrd,

[Pettersson, et a l ,
1986].

Previously

12 1

mentioned physiological explanations Include:

1)

multiple orders of

non-interacting binding sites with unchanging and dissimilar
affinities*

2)

multiple affinity states of the receptor exlsitng as a

consequence of receptor-hormone coupling when a variable fraction of
the total receptor population is coupled to the hormone or 3) negative
cooperatlvity [Llmblrd,

1986; Gammeltoft,

1984].

The results of the

dissociation curves where "infinite dilution + excess Insulin"
dissociated faster than the "infinite dilution", supports negative
cooperatlvity, although this finding is not pathognomonic [Levitski,
1981].
Previously mentioned technical problems can also cause the
curvilinear shape to the Scatchard plot.
1)

Artifactual causes include:

inappropriate definition of non-specific binding,

2)

the

aggregation of the ligand at higher concentrations to a dimer or
multlmer that possess a lower affinity for the receptor and 3) a
difference in the affinity or kinetic constants of [*H] and [H], such
that the receptor possesses a greater affinity for r*H] than [H]
[Pettersson, et a l , 1984; Limbird,

1986],

Recent studies have supported the concept that the terminal
horizontal part of the Scatchard plot is artlfactual and strongly
influenced by non-specific effects [Pettersson, et a l , 1984],
Independent studies have shown that a small error in the determination
of non-specific binding can significantly alter the number of receptor
sites calculated from the Scatchard plot while the

X

maximum binding

remains relatively unchanged rSllberring & Wallgorski,
To avoid these pitfalls,

1985].

it has been suggested that only those

points obtained from physiological concentrations of insulin be used.
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As a general rule, the highest concentration of the ligand In the
saturation assay of hormone receptors, should be at least 5 to

10

times the dissociation constant, which roughly represents the normal
plasma concentration of the hormone (0.1-10 ng/ml)
1984],

[Pettersson, et al,

In this study, unlabeled Insulin concentrations ranged from

0-1 X 104 ng/ml.

The high-affinity portion of the curve (vertical)

included insulin concentrations from

0

to

100

low-afflnity portion of the curve (horizontal)

ng/ml, while the
Included insulin

concentration from 150 to 5000 ng/ml.
Two findings In this study support the previous theory that the
horizontal portion of the curve may be artlfactual.

First is the

finding of greater variation In parameters obtained from the
horizontal portion of the curve (total number of receptor sites,
low-afflnity K^) as compared to parameters obtained from the vertical
portion of the curve (high-affinity receptor sites, high-affInity K^)
in both liver membrane and erythrocyte assays [Tables 5 &

8

].

calculated from data obtained from both portions of the curve.
is the finding of significant correlation between

X

Ke is
Second

maximum binding

versus high-affInity receptor sites and Ke and negative correlation
between

II.

X

maximum binding versus high-affInity K^ [Tables 1 & 2],

INSULIN RECEPTORS OF CANINE LIVER MEMBRANES AND ERYTHROCYTES

The purpose of using liver membranes was to evaluate an organ
considered to be a major target organ for insulin in the body.
use of crude liver membrane preparations offered advantages and
disadvantages.

This type of preparation was relatively easy to

The
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prepare and minimized potential alterations In receptors due to
manipulations carried out in more sophisticated solubilization
techniques [Kahn, 1976].

However, these crude membranes were more

contaminated with mitochondrial and microsomal proteins and tended to
have higher non-specific binding.
Although the physiological significance of insulin receptors on
erythrocytes Is not known, erythrocytes are useful In evaluating
various physiological states in a clinical setting.

The easy

accessablllty to large numbers of cells by way of venipuncture is an
obvious advantage [Gambhlr, et a l . 1978; Dons,

1981; Im, et a l , 1983;

Peterson, et a l , 1983; Ogunwole, et a l , 1985].
A potential disadvantage that has been proposed Is that
erythrocytes are not classic target cells for Insulin.

Previous

studies have shown correlation between Insulin binding of erythrocytes
and monocytes [Ward, et a l , 1981; Kobayashl, et a l , 19801 and
erythrocytes and hepatocytes, although in the latter study erythrocyte
receptors were less sensitive to changes In Insulin than were
hepatocyte receptors fOkamato, et a l , 19821,

One of the purposes of

this study was to attempt to correlate Insulin binding of liver
membranes and erythrocytes.

While the results did not show a

significant correlation between any of the binding parameters
evaluated, it is possible that correlation might be masked by the high
variation within and among dogs ^Tables 5 &

8

], as well as the high

Interassay coefficient of variation for the liver membrane assay.
While attempts at correlating insulin binding parameters of
canine liver membranes and erythrocytes were Important, comparisons,
between tissues, of mean values for various parameters would have been
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meaningless.

The 2 assays were carried out under different Incubation

temperatures and pH's.

The differences in Incubation conditions could

account for differences in affinity constants even within the same
tissue, making this comparison of no value.

The number of receptor

sites were determined per erythrocyte In one assay and per plcogram of
protein In the other assay.

Therefore, a comparison of the number of

receptor sites would also have been meaningless.
Even though correlations were not evident between liver membranes
and erythrocytes. It can be argued that receptor binding observed for
both tissues represented binding to the physiological receptor for
Insulin [Llmblrd, 1966],

Differences In binding parameters of liver

membranes and erythrocytes may have been due to differences In
receptor regulation TPeterson, et a l , 1983].
In addition, It Is noteworthy that In both liver membrane and
erythrocyte binding studies, there was a correlation between the %
maximum binding versus the number of hlgh-affinity sites and Ke and a
negative correlation between !S maximum binding versus high-affinity
[Tables 1 & 2].

This indicates that the total binding is a function

of receptor number and affinity for both liver membranes and
erythrocytes.
The argument that mature erythrocytes cannot up/down regulate the
number of receptor sites because they lack nuclei, has been
sufficiently overcome by the finding that receptor site numbers can be
regulated by "internalization", a process not requiring de novo
protein synthesis rcambhir, et al, 1981; Bathema, et al, 1981;
Peterson, et a l , 1983].
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III.

THE EFFECTS OF SEX ON CANINE INSULIN RECEPTORS

In previous studies■ human erythrocyte Insulin binding has been
shown to be senstlve to variations in plasma sex hormone
concentrations [Bertoll, et al, I960; Hendricks, et al, 1981; Ohgaku,
et a l , 1981; Pettersson, et al, 1984],

Binding In all studies was

found to be lower In females than males.

Some studies attributed this

difference In binding to differences In receptor concentration
[Bertoll, et a l , 1980; Henderlcks. et a l , 1981; Pettersson, et a l .
1984] or differences In affinity [Ohgaku, et al, 19811.

When various

phases of the menstrual cycle were compared, it was found that Insulin
binding at the luteal phase was significantly lower than that of the
follicular phase [Bertoll, et a l , 1980].
In the present study, no significant differences were observed In
either liver membrane or erythrocyte binding parameters due to sex.
There was an Insignificant increase In the total number of binding
sites and decrease In affinity of the low-afflnity receptors for
erythrocytes from females, but as previously discussed, these binding
parameters are probably not physiologically important.
The observation that there was a significantly higher variation
among female dogs than a pooled value representing "within dog"
variation, than among males for

%

maximum binding and the number of

high-affinity binding sites, could be attributed to the fact that the
6

female dogs were In various stages of the estrous cycle throughout

the study [Appendix 5].

Because only

6

bitches were evaluted, no

accurate comparison of binding parameters to stages of the estrous
cycle could be made.
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IV.

THE EFFECTS OF ANESTHESIA ON CANINE ERYTHROCYTE INSULIN RECEPTORS

In evaluating 9 dogs on one occaBBion, this study was able to
demonstrate a significant Increase In the X maximum binding as a
result of anesthesia [Table 9].

This finding Is Important to keep In

mind when comparing data obtained from research animals where
anesthesia or chemical restraint may be utilized to clinical
situations where anesethesla Is not required for blood collection.

V.

THE EFFECTS OF PREDNISONE ON GLUCOSE TOLERANCE, INSULIN SECRETION

AND INSULIN RECEPTORS IN DOGS

The results of the present study, using prednisone, were similar
to previous studies done by our group, using prednisolone, with regard
to glucose tolerance and insulin secretion ^Figures 24 & 25; Appendix
6

].

In the earlier study, we found that only the fasting plasma

glucose concentration was significantly increased (p < 0.05) as a
result of glucocorticoid treatment

(2

mg/kg); whereas,

in the present

study, the increase in fasting serum glucose concentration after
prednisone (1.25 mg/kg> approached significance (0.10 > p > 0.05).
both studies,

changes

In

in Insulin secretion noted were insignificant

( p > 0. 10) .
In the present study, body weight and food intake were closely
monitored to assure that any observed changes in insulin receptors or
insulin sensitivity would be attributed to glucocorticoid
administration rather than obesity.

Food intake was maintained at a
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constant level that had previously maintained an Ideal body weight.
In spite of this, a significant decrease In body weight averaging 1.1
kg/dog, occurred fTable 12],

The decrease in body weight was most

likely due to the catabolic effects of glucocorticoids.
The insignificant increases in the

X

maximum binding and the

total and high-affinity receptor sites observed at 52 hours in the
dogs treated with prednisone were similar to the results of a previous
study, where a significant Increase In the

X

maximum binding and

receptor concentration were observed 1 day after the IV administration
of 1 mg/kg of dexamethasone fDieberg, et a l , 1986].
The changes seen in the present study may have been more subtle
than the earlier study, because of the difference In route of
administration, glucocorticoid formulation or, more likely, due to a
smaller dose potency on a body weight basis.
The insignificant Increases in the total number of receptor sites
and decreases in low-affinity

after 3 weeks were unlikely to be of

physiological importance,since these parameters were obtained from the
horizontal portion of the Scatchard plot.
physiologically important,

If these changes were

they were likely due to a direct effect of

glucocorticoids on the receptor rather than an indirect effect
mediated through circulating blood levels of insulin (up/down
regulation),

since there was no significant change In serum insulin

concentrations (observed fasted or when stimulated with glucose
administration) due to glucocorticoid treatment.

If the Insignificant

increases in serum glucose (observed fasted and after glucose
administration) due to glucocorticoid treatment, were physiologically
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Important, a possible explanation would be that of Insulin resistance
mediated via post-receptor mechanisms.
Since the conclusion of this original study, additional clinical
studies have been performed, utilizing the erythrocyte receptor assay
^Personal o b s e r v a t i o n s K

A healthy population of pet dogs ranging in

age from 1 to 16 years of age (n“ 9 ) , a group of dogs with Cushing's
syndrome (n«9), and a group of dogs with diabetes mellitus (n*6 ) were
evaluated.

Mean values of binding parameters for the healthy

population were similar to the healthy dogs in the original study (*;
maximum binding “ 4.55 versus 5.28).
had significantly decreased binding

The dogs with Cushing's Syndrome

(X

MB ■ 2.32) while the dogs with

hypolnsulinemlc diabetes mellitus had significantly increased binding

(X

MB * 7.88) when compared by an unpaired t test

(p<0.05).

These

results support the potential usefulness of the erythrocyte insulin
receptor assay as a clinical research tool for use in dogs.
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CONCLUSIONS
Demonstration of receptor association, dissociation, saturablllty
and specificity supports the theory that binding sites observed In
these studies represent the physiological receptor for InsulIn on
canine erythrocytes and liver membranes.
Insulin receptor binding parameters, Including the % maximum
binding, total numbers of receptor sites, high-affinity receptor
sites, low-affinlty K^, high-affinity

and Ke, were made from

Rosenthal/Scatchard plots and average affinity profiles.
of high-affinity receptor sites and high-affinity

The number

were considered

to be more physiologically important than the total number of receptor
sites, low-affinity

and Ke.

The former parameters were obtained

from data using physiologic concentrations of Insulin whereas the
latter parameters were obtained from data using supra— physiological
concentrations of insulin.

Values for the % maximum binding

correlated with the number of high-affinity receptor sites and Ke and
negatively correlated with high-affinity K^.

This finding indicates

that insulin receptor binding is a function of both receptor numbers
and affinity.
Interassay coefficient of variation (CV) was determined to assess
precision for both the erythrocyte and liver membrane assays.
Interassay CV was 9.3 % for erythrocytes and 25.OZ for liver membranes.
The precision for the erythrocyte assay allows this assay to be a
useful clinical research tool.

The poor precision for the liver

membrane assay, using the technique described In this study, makes
this assay unreliable for clinical research purposes.
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While changes In erythrocyte insulin receptor binding may not
parallel changes in liver insulin receptor binding, as evidenced by
results of this study and previous studies [Okamoto, et a l , 1982],
Insulin receptor binding still represents the physiological receptor
for insulin on erythrocytes and liver membranes. This difference in
binding may be due to different mechanisms of regulation of receptor
numbers and/or affinity [Peterson, et a l , 19831.

It is worthwhile to

continue to evaluate erythrocyte insulin receptor binding in clinical
diseases or situations where insulin abnormalities are suspected, in
an attempt to better understand the multi-faceted aspects of insulin
function.
No significant differences were observed in mean values for
binding parameters observed when comparing male versus female dogs
with either liver membranes or erythrocytes.
significant variation of the

X

However, there was

maximum binding and the number of

high-affinity receptor binding sites for erythrocytes among the dogs
evaluated (variation of high-affinity

approached significance).

This variation among dogs was significant for only female dogs and
possibly attributable to cyclic variation in sex hormones occurring in
the reproductively intact cycling female dogs used in the study.
Significant Increases in the % maximum binding of erythrocyte
lnsulIn receptors, observed as a result of anesthesia, emphasizes the
point that comparisons of results obtained from unanesthetized animals
(clinical cases) to results obtained in a research setting, where
anesthesia or euthanasia is Involved in tissue/cell collection, should
be done cautiously.

13 1

Significant changes In erythrocyte insulin binding were not
observed In male dogs given prednisone when parameters were evaluated
at 52 hours and 3 weeks after the onset of
Insignificant Increases in the

X

dally oral treatment.

of maximum binding and the total

number of receptor sites and high-affinity receptor sites were
observed after 52 hours.

An insignificant Increase in the total

number of receptor sites and decrease in low-affinity
observed after 3 weeks of treatment.

was also

If these Insignificant changes

were physiologically important, they were most likely due to a direct
effect of glucocorticoid on the receptor rather than an indirect
effect mediated through circulating blood levels of insulin (up/down
regulation).

There were no significant changes in serum insulin

secretion (observed at rest or when stimulated with glucose
administration) due to glucocorticoid treatment.

If the insignificant

Increases in serum glucose (observed at rest and when stimulated by
glucose administration) due to glucocorticoid treatment were
physiologically important, a possible explanation would be that of
Insulin resistance mediated via post-receptor mechanisms.
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FOOTNOTES
a

Pork mono 1125 insulin and porcine insulin* Dr. Bruce Frank* Dept, of

Biochemistry, Lily Research Laboratories, Lily Corporate Center,
Indianapolis, Indiana.
b

Glucagon, Sigma Chemical Company, P.O. Box 14508, St. Louis, Mo,

63178.
c

Porcine proinsulin, Dr. Bruce Frank, Dept, of Biochemistry, Lily

Research Laboratories, Lily Corporate Center, Indianapolis, Indiana,
d

Desoctapeptlde insulin, porcine, L'. Salvatore Raltl, National Hormone

& Pituitary Program, University of Maryland School of Medicine, Suite
501-9, 210 West Fayette Street, Baltimore, Maryland 21201-3472.
e

Homogenlzer/Bench Top Drill Press, Model 47660A, Dayton Electric Mrg

Co., Chicago,
f

Illinois, 60648.

Bechman Model J21B Centrifuge, Bechman Industries, Inc., Palo Alto,

Calif., 94304.
g

Spectronic 2000, Bausch and Lomb, Analytical Systems Division,

Rochester, New York 14625.
h

Eppendorf Micro test tubes,

Westburg, N.Y.
i

1.5 ml, Brinkmann Instruments, Inc.,

11590.

Fisher Microcentrifuge, Model 235A, Fisher Scientific Company, 526

Routee 303, Orangeburg, New York,
j

10962.

Serle Automatic Gamma System, Model 1185, Searle Analytic Inc., 2000

Nuclear Drive, Des Plaines, Illinois, 60018.
k

Model TJ - 6 Refrigerated Centrifuge, Beckman Industries Inc., Palo

Alto, Calif., 94304.
1

Trichloroacetic acid, Malllnkrodt Co., Paris, Kentucky 40361.

m

CPD-A1, Terumo Corporation, Tokyo, Japan.
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n

Hlstopaque, #1077-1, Sigma Chemical Co., P.O. Box 14508, St. Louis

Mo. 63178
o

Hemocytometer, American Optical Corporation, Buffalo, New York,

14215.
p

Eppendorf Micro Test Tubes, 400 ul. Polypropylene, Brinkmann

Instruemnts, Inc., Westburg, N.Y.

11590.

q Dibutyl Phthalate, Sigma Chemical Co., P.O. Box 14508, St. Louis, Mo.,
63178.
r

Marshall Research Animals, North Rose, New York 14516.

s

Canine Maintenance Dog Food, Science Diet, Hills Pet Products, P.O.

Box 148, Topeka, Kansas 66601.
t

Statzyme glucose, Worthington Diagnostic Systems, Inc., Freehold, New

Jersey.
u

Insulin coat-a-count radioimmunoassay. Diagnostic Products

Corporation, Los Angeles, Calif.
v

Ivomec, MSD AGVET, Merck, and Co., Inc., Rahway, New Jersey, 07065.

w

Pentothal sodium. Chemical and Agricultural Products, Division,

Abbott Laboratories, North Chicago, Illinois, 60064.
x

Metofane— methoxyfluorane, Pitman-Moore, Inc., Washington Crossing,

New Jersey, 08560.
y

0.9% Saline, Travenol Laboratories,

Inc., Deerfield,

Illinois, 60015.

z

Laparoscope, Richard Wolf Medical Instruments Corporation,

7046

Lyndon Avenue, Rosemont, Illinois, 600018.
aa

Storz biopsy forcep, Karl Storz,

101II West Jefferson Blvd, Culver

City, California, 90232.
bb

prednisone, AMFAC Veterinary Supply Company, Atlanta, Georgia,

30318.
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APPENDIX 1 - Assay Buffers

A.

0.25 M SUCROSE 5 mM TRIS BUFFER

PH - 8.0
Gram/Liter

Sucrose
Tris Buffer Base

B.

85.6
0.60

BUFFER L
KREBS-RINCERS- PHOSPHATE BUFFER
CONC.
NaCI
KCI

PH - 7.4
GRAM/LITER

118 mM

6.88

5 mM

0.37

MgSO^4.7H20

1.2 mM

KH-PO,
2 4

1.2 mM

0.16

NaHPO.
4

25 mM

3.55

CaCl 2 .2H20
BSA*

* Bovine Serum Albumin

1.3 mM
IX

0.30

0.147
10.0
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APPENDIX 1 continued

C.

PHOSPHATE BUFFERED SALINE (PBS)

PH - 7.4

20X

GRAMS/LITER

NaCl

160

KC1

4

Na-HPO.
2
4

23

KH„PO,
2 4

4

then add 50 ml to distilled water to q.s.

D.

BUFFER G

1 liter

PH - 7.6
mM/Liter

Crams/liter
13.0

HEPES Buffer

50

Tris pH 7-9

50

6.06

MgCl,,.6H00

10

2.03

2

0.67

Dextrose

10

1.80

NaCl

50

2.92

5

0.37

10

1.47

EDTA (DiNaSalt)

KC 1
CaCl 2 .2 H 2 0
BSA*

♦Bovine Serum Albumin

10.0
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APPENDIX 2

3.

LOWRY SOLUTION

50 PARTS

"LOWRY A"

: Na 2 C0 3
NaOH

20 grams/liter
4 grams/liter

NaK Tartrate 0.2 grams/liter
1 PART

"LOWRY B"

IX CuSO..5H_0
4
2

APPENDICES

APPENDIX 3

CPD-AI
Citrate Phosphate Dextrose Adenine Solution (63 ml)
contains:

Citric Acid Hydrous

206 mg

Sodium Citrate Hydrous

1.66 grams

Monobasic Sodium Phosphate Hydrous

140 mg

Dextrose Anhydrous

1.83 grams

Adenine

17.3 mg
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APPENDIX 4

CONTENTS OF CANINE MAINTENANCE DIET (DRY)

Carbohydrate

45.92

Protein

23.02

Fat

14.52

Fiber

3.32

kcal/gram

3.9

calories/cup

336
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APPENDIX 5
VAGINAL CYTOLOGY OF SIX BITCHES DURING STUDY

Week
Dog

2-19-86

3-5-86

3-21-86

4-5-86

4-18-86

5-2-86

5-16-86

5-30-86

__________Sampling__________
I

D

D

A

A

A

A

A

A

D

D

D

A

A

A

2

E

D

4

A

7

P

A
P
-----E
D

8

P

E

D

D

D

D

A

A

12

A

P

E

D

D

D

D

A

A “ Anestrus
E * Estrus
D “ Diestrus
P * Proestrus

E
D
----- -— — --------D
D

D

D
D
Sampling_________
D
A
A

Appendix 6
"Effects of prednisolone on glucose tolerance
and insulin secretion in the dog"

K.J. Wolf shelnier, W. Flory, M.D. Williams
American Journal of Veterinary Research
Volume 47, Number 5, May 1986
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Effects o f prednisolone on glucose tolerance and insulin
secretion in the dog
K J W o ifth tim tr, DVU. W Flory. PhD; U D. WiUiom*, D V U , PhD

SUMMARY
Effects o f prednisolone on glucose tolaranca and in su lin
secretion w o n oval u s lad in Iw hlqF d o p . D o p were given
1 m g of pr*dnieolone/kg of body w eight/day In *■ 5) or 2
m g of pradniaolona/kg/day In ■ 6) orally for 3 w eeks
In tra v en o u s glucooo tolaranca taata <600 m g/kg) worn ad 
m in iste re d before and a fta r tre a tm e n t to av a lu a ta p lasm a
glucoaa in fa ttin g doga, glucoas fractional clearance ra ta ,
■arum insulin in fastin g dogs, in su lin p aak rasponss, to ta l
in su lin aacra tion, and insulinoganic indax.
A signiA cant difference (7* < 0.06) in plasm a glucoaa
in Easting dogs w as obasrvsd for tb a 2 mg/kg dose, a l
though values w ars still w ithin th a reference rang* T hsra
w as no signiA cant offset on g lucoas fractional claaran ca
ra ta Iglucoaa tolaranca) or insulin secretion. Seem ingly,
p erip h e ra l in su lin resistance re su ltin g in hyperinaulinem is or decreased glucoaa tolerance could not be identified
in association w ith 1 or 2 mg of predm eolone/kg/day for
3 w eeks in h ea lth y dogs.

In h u m an b eings a n d rats, glucocorticoids can induce
insulin resistan ce a t th e ta rg e t cell a n d therefore resu lt
in hyperglycemia.**"**1 T he m ech an ism for in su lin re 
sistan ce ia u n c e rta in .•* 1#"
W ith in su lin resistan ce, a com pensatory action occurs
in th a body re su ltin g in increased c irc u latin g insulin con
ce n tratio n s to effect p ro p er glucoaa u se .'* Prolonged ex
cessive stim ulation of pancreatic 6 cells to produce insulin
in a situ atio n of in su lin resistan ce could resu lt in ex 
h au stio n of tb s 6 cells and th u s lim it in su lin secre
tion.**11 T h e re su lt of lim ited in su lin secretion or a
pronounced in su lin resistan ce is hyperglycem ia and re 
lated m etabolic d eran g em en ts in association w ith gluco
corticoid excess A lthough hyperinsulinem ia may be caused
by in su lin resistan ce, th e re is also evidence to support a
d irect stim u lato ry effect o f glucocorticoids on 0-cel) se
cretion.* *■
T h e purpose of th e p rese n t rep o rt w as to ev alu ate th e
effects of sh o rt-term prednisolone tre a tm e n t on h ealthy
dogs. P lasm a glucose an d serum in su lin concentrations
w ere m easu red in response to a n rv does of glucoes as a
m ean s of ev a lu a tin g a lte ra tio n s in glucose/insulin ho
m eostasis caused by prednisolone tre a tm e n t.

Materials and Methods
Dog*—Eleven healthy adult doge <6 males, and 6 sneetrsl
In th e dog, secondary diab etes m ellitua h as bean asso
ciated w ith glucocorticoid excess ' T h a concurrent p re s females) were conditioned to housing and • commercial dog food*
carbohydrate dry weight! for 2 weeks. These dogs were of
ence of diabetes m ellitua an d hyperadrenococticism ia <41%
various breeds, ranged in body weight from 17.3 to 29 5 kg. and
reported in th e dog.11 Glucoaa in tolerance an d o v ert d i were within 10% of ideal body weight. A constant amount <30
ab etes m ellitua developed in a dog a fte r prolonged exog g of dog food/kg of body weight) was fed daily and water was
enous ad m in istra tio n of glucocorticoids *
given ad libidum.
Hyperglycemia associated w ith glucocorticoid excess may
The dogs were seeigned to 2 groups. One group (3 males and
be caused by increased hepatic gluconeoganeeis, as well 2 females) wee given 1 mg of predniaolone/kgrdisy orally The
a s decreased u se of glucose in tissu es.'* * A lthough in  other group (3 males, 3 females) was given 2 mg of prednisolone/
creased hepatic gluconeogeneeia caused by glucocorticoid kg/day orally. Both groups were treated for 3 weeks.
Intravenous glucose tolerance tests w on performed before and
ad m in istra tio n in th a dog is well docum ented,1 * th a e v a l
u atio n of p erip h eral glucoas u p ta k e in association w ith after the 3-week treatm ent in each dog. Doge were fasted 24
hours before administration of 600 mg of gluooaa/kg iriven as
in su lin function is n o t a s w ell d escr ibed in th a dog a s it 50% dextrose) over a 30-e period via cephalic catheter. TTui dose
ie in h u m an beings.1
allowed maximal stimulation of insulin secretion without uri
In relatio n to glucose u ptake, in su lin facilitates glucose nary loas of glucose during the IS to 45 minutes when fractional
tra n sp o rt across call m em branes in m uscle, adipose, o th e r clearance rates of glucose w e n determined " This does gave
tissues, a n d leukocytes, a s well a s allow ing phosphory results sim ilar to those obtained with the more widely accepted
lation of glucose in th a liv e r 1* In su lin in te ra c ts w ith spe dosage rate of S00 mg of glucose/kg.^** Glucose determinations
cific call m e m b ra n e re c e p to rs to i n it ia t e a s e rie s o f before IS minutes were not used in the determination of frac
in tra c e llu la r postreceptor events, including glucose u ti tional clearance rates, because those values exceeded the renal
threshold, therefore, they would result in urinary lose of gluroaa
lisation.
which would inaccurately increase fractional clearance rate.**
« e i — SfcuQliX
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Plasma glueot* ctmmnfrorioae—All blood samples were col
lected through an indwelling jugular catheter and taken before
and 5, 10. IS. 26, 35. 45 a id 60 minutes after glucose administration. Serum samples far insulin values were collected, al-PanaaS| Aw. XalaiaePunasCu StUna Mu
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lowed to clot, w o n centrifiiged, and imm ediately asperated and
frusen o t - 20 C until assayed. Plasm a sample* for glucose con
centration* w o n colloctod in EDTA. im m ediately centrifiiged,
and froaan a t - 20 C, Oluooao concentration* w o n dotonninod
■pectrophotometrically, uaw g tho flucooo oxidase method.* A
reference rang* of can in# plasm a flucooo concentration wao detorminod from 26 healthy do(* to bo botwoon 80.0 to 106.0 mg/
d! w ith a moan of 93.6 ( ± 1 s o - 8.6)
Scrum insulin conconlruttono—Inaulin valuoo for oorum *ampleo w o n dotonninod by rndioimmunoaoaay, uaing a commer
cially available kit for uao in hum an being*' Specificity for
canine inaulin waa evaluated by dem onatrating dilutional parallelitm between atondard aolutiona and aerial dilution* of en 
dogenous inaulin in canine oorum Biological apociflcity waa
dem onstrated by rovaaling injected glucooe atiraulated an incraaao in aerum inaulin concontrationa in hoalthy dog*, a* well
aa by th e m oaaunm ent of incnaaod inaulin concontrationa (64
pJU'ml i in a faated dog w ith hiatologically confirmed pancreatic
6-cell adenocarcinoma. Accuracy waa dem onatrated by the ad 
dition of porcine inaulin fbocaue* the am ino acid sequence waa
identical for porcine and canine inaulin and purified canine in 
aulin waa unavailable) to canine aerum in concontrationa from
4 to 200 p JU m l Linear legi aaaion analysis of the recovery curve
dem onatrated a correlation coefficient (r) of 0 998 Low-end eenaitivity for th e aaaay, defined a* the apparent concentration 2
SD below the counts at m aaim um binding, waa 1
The intra-aaaay preciaion for 18 replicate* (9 duplicated a tm
plea) of canine aerum with a m ean concentration of 38 3 pIU/
ml revealed a coefficient of variation of 3.7%. The interaaaay
coefficient of variation for 9 aaaay* on th e aame canine aerum
aample waa 13%.
The reference range of inaulin concentration* in canine *enim
determ ined from 61 healthy dog* of various breed* (31 male*
and 30 aneatral females), waa 2 6 to 20.0 p lU m l The m ean was
7 8 I ± I so - 3.9)
The following wore evaluated from th e rv glucoae tolerance
test: (i) plaama glucoae concentration in fasting dog*, fii) frac
tional clearance rate of glucoae, (iii) aerum insulin concentra
tion in fasting dog*. Iiv) insulin peak response, (v) total inaulin
aaerated, and <vi) insulinogenic index.
The fractional clearance rate was calculated a* the slope of
the line (0 693/half-life I t i J * 100, aa percentage per m inute)
for plasm a glucose values tak en between 15 and 45 m inutes 11M
The insulin peak response w as considered to be th e highest
increm ent of aerum inaulin above the base-line (aample taken
before rv glucoae) aerum inaulin concentration. Total insulin
aacration waa estim ated aa the total increm ental insulin are a
above th e base line during the 60 m inutes of the teat The meulinogenic index was defined as the ratio of insulin peak re
sponse to the greatest glucose increment above the concentration
in fasting dogs (5 m inutes) *1
S tatistical analysis was performed uaing the paired t teat IP
< 0.05) “

Results
All doga developed clinical aigns of hyperglucocorticoidism, including polyuria, polydipsia, and increased ap
petite.1'4 Although aonie doga had pendulous abdomens
and m uscle w asting, there were no significant changes in
body w eight for the treatm ent groups.
Plasm a glucose concentrations in fasting dogs w ere sig
nificantly increased after treatm ent w ith the 2 mg/kg
dosage (P < 0.05). The mean glucose plasma concentra
tion in fasting dogs increased from 87 mg/dl to 97 mg/dl,
* a u u j m f t w a a , W w tU aetsa D i s e n l i t iywtimt lac. frasbaid NJ
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Fig t — E ffect* ol p red n isolon e o n g lu c o s e tolerance during tv g lu c o se toie r e n c e le e t (6 0 0 m g-kgf O
% - m e a n v a lu e s tor healthy nontreaied
dog* (n - 11).
- m e a n valu e* tor d o g * treated with t m j d
D red m soton e/k gd ey (n - 6). and A
A “ m e w i v e to e s tor dog* treated
wMi 2 m g erf prednw otoneiig/daiy

although rem aining w ithin the reference range (87.0 to
101.0 mg/dl). T his range w as determ ined by use of the
sam e procedure for glucose determ ination on plasma
samples from 2$ healthy dogs.
After prednisolone w as given to the doga, m ean glucoee
fractional clearance rates slightly increased in those given
the 1 mg/kg dosage and slightly decreased in those given
the 2 mg/kg dosage N either changes were significant iP
> 0.05; Fig 1).
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There w ere no significant changed in inaulin value* in
fasting dogo or in inaulin peek reaponae in either group
when compered with pretreatm ent veluee. Decreaeea in
mean totel inaulin secretion were obeerved in both groupe,
but were not significant A change waa not noticed in the
inaulinogenic index for the 1 mg/kg doee group, but there
waa an insignificant decrease in the 2 mg/kg doaage group
(Fig 2)

Discussion

tissues.*0 17 In acute studies, m ethyl prednisolone or cor
tisol decreased or did not affect glucose production and
utilization.7 ** More prolonged glucocorticoid excess (5 to
7 days) causes an increase in glucose production and u ti
lization.7 * In 1 stu d y,17 the increased rate of utilization
may have been inappropriate for the degree of hypergly
cem ia and hyperinaulinem ia, thus reflecting a relative
peripheral insulin resistance.
The increased glucose concentrations in fasting dogs
after 2 m g h g treatment with prednisolone could be caused
by a decreased inaulin suppression of hepatic gluconeogenesis (hepatic insulin resistance). The lack of increase
in serum insulin values (lasting or in response to glucose
challenge) indicates that peripheral inaulin resistance was
m inim al or nonexistent. However, peripheral insulin re
sistance cannot be ruled out, because values measured in
the present study were lim ited. Dem onstration of periph
eral inaulin resistance may require elaborate glucose clamp
techniques, monocompartmental analysis, uaing tritiumlabeled glucose, and m inim al model m ethods.1* 17 **
The mechanism for insulin resistance ia uncertain.*1011
Increases and decreases in inaulin receptor numbers1* 1*J0**
and affinity1* 10 ia 10111411 have been found in studies of
in su lin receptors on h epatocytes.*4 " ad ip ocytes,19 47
erythrocytes,1*10 ,1 and leukocytes.1* 1*'10 These conflict
ing results may reflect differences in experim ental design
and duration, different tissue effects o f glucocorticoids, or
differences in glucocorticoids used in the studies.11 One
proposed explanation for the discrepancies seen in var
ious studies is that increases in receptor numbers or af
finity may be caused by a direct effect of glucocorticoids,
whereas the decreases in receptor numbers or affinity may
reflect a secondary response to increased circulating in
sulin values directly caused by glucocorticoids (so-called
d ow n-regulation).17■l* Insulin resistance of glucocorti
c o id s m ay a ls o b e c a u se d by p o str e c e p to r de-

The hyperglycem ia and glucoae intolerance seen with
The findings of decreases in insulin peak response and
glucocorticoid exceaa ere aaaociated with hepatic and pe
ripheral inaulin resistance.*101* Inaulin usually acta to total insulin secretion were surprising, because an in
suppress enzym es involved in hepatic gluconeogenesis,7 * crease in insulin secretion would be expected with glu
aa well ea to facilitate glucose utilization in peripheral cocorticoid excess * 1414 Increased insulin secretion would
Am
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be oxpeetod b*c«ui* glucocorticoids may in crau o inaulin
aacration indirectly by inaulin rasiatanca and/or by hav
ing a direct stim ulatory affect on steroid receptor* on pan
creatic 0 cells to increase inaulin secretion directly * 7
Peterson at al'-* found an increase in insulin peak re
sponse and total insulin secretion in 8 dogs with hyperadrenooortidsn. With longstanding hyperadrenooortidsni
and p-call exhaustion, decreases in inaulin values in fast
ing dogs, insulin peak response, and total inaulin secre
tion may be eeen.1*11 TV* decrees ss in insulin peek response
and total insulin secretion were not significant and prob
ably not physiologically important in view of absence of
significant changes in glucose fractional clearance rates
and absence o f histopathologic changes in pancreatic islet
cells in 4 dogs exam ined histologically.
Peripheral insulin resistance in healthy dogs is m ini
mal at doses of 1 and 2 m g o f predniaolone/kg/day for 3
weeks and is not detectable by the values evaluated. Uee
of more sophisticated techniques may be effective in doc
um enting insulin resistance in dogs in the future From
a clinical standpoint, healthy dogs have th e capacity to
tolerate therapeutic doses of glucocorticoids for short pe
riods w hile m aintaining glucoee/insulin homeostasis.
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Amer i can J o u r n a l V e t e r i n a r i a n
Research
930 N. Meacham Road
Schaumberg, IL 60196
Dear Or . K o l t v e i t

I am writing to request permission to reproduce the article "Effects of
prednisolone on glucose tolerance and Insulin secretion in the dog". Am. J.
Vet. R e s . , 47(5) 1011-1014, 1986. I am the primary author and would Yilce 'Eo
include a reprint of the article in the appendix of m y PhD dissertation at
Louisiana State University. The reprint would be reprinted in the form that
it was published 1n your journal with full credit to Am. J. Vet. Res. Thank
you for your consideration.
Si n c e r e l y ,
r
-

Karen J. Wolfsheimer, DVM
KJW:mrs
September 29, 1986
Permission granted provided that the reprinted article is reproduced exactly
as originally published and without any alterations, additions, or deletions.

A. _ . ------- , --Editor-in-Chief

AJK;rj

V ITA

Karen Johnson Wolfsheimer was born In Huntsville, Alabama on July
27, 1953 and graduated from Huntsville High School In 1971.

She

received the Bachelor of Science degree with High Honors in Laboratory
Technology from Auburn University in 1976 and the Doctor of Veterinary
Medicine degree with Honors from Auburn University in 1978.

She

completed a one-year Internship in Small Animal Medicine and Surgery
at Purdue University in 1979 and a two-year residency in Small Animal
Internal Medicine at the University of Florida In 1981.

She was

engaged In the private practice of veterinary medicine in Statesville
and Kernersville, North Carolina in 1981-1982.

In 1983, she was

accepted Into the graduate program of the Department of Veterinary
Physiology, Pharmacology and Toxicology, School of Veterinary
Medicine, Louisiana State University, as a graduate assistant.

In

June of 1985, she was granted Dlplomate status In the American College
of Veterinary Internal Medicine.
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